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(57) 	 ABSTRACT 
Selecting which sub-sequences in a database of nucleic acid 
such as 16S rRNA are highly characteristic of particular 
groupings of bacteria, microorganisms, fungi, etc. on a sub-
stantially phylogenetic tree. Also applicable to viruses com-
prising viral genomic RNA or DNA. A catalogue of highly 
characteristic sequences identified by this method is 
assembled to establish the genetic identity of an unknown 
organism. The characteristic sequences are used to design 
nucleic acid hybridization probes that include the character-
istic sequence or its complement, or are derived from one or 
more characteristic sequences. A plurality of these character-
istic sequences is used in hybridization to determine the phy-
logenetic tree position of the organism(s) in a sample. Those 
target organisms represented in the original sequence data-
base and sufficient characteristic sequences can identify to the 
species or subspecies level. Oligonucleotide arrays of many 
probes are especially preferred. A hybridization signal can 
comprise fluorescence, chemiluminescence, or isotopic 
labeling, etc.; or sequences in a sample can be detected by 
direct means, e.g. mass spectrometry. The method's charac-
teristic sequences can also be used to design specific PCR 
primers. The method uniquely identifies the phylogenetic 
affinity of an unknown organism without requiring prior 
knowledge of what is present in the sample. Even if the 
organism has not been previously encountered, the method 
still provides useful information about which phylogenetic 
tree bifurcation nodes encompass the organism. 
21 Claims, 15 Drawing Sheets 
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LOCUS 	 E.colirnA3 3714 by 	 RNA 	 RNA 	 09-NOV-1998 
DEFINITION Escherichia coli atr. MG1655 (gene-rreA gene]. 
REFERENCE 1 
AUTHORS 	 Blattner,.F.R.,, Plunkett,.G.,,III,,..Bloch,.C.A.,. Perna,.N.T., Burland,V., 
Riley,M-.,- Collado-Vides;J.-, Glasner,J.D., Rode;C..K., Mayhew,G.F., 
Gregor,J., Davis,N.W., Kirkpatrick,H.A., Goeden,M.A., Rose,D.J., 
Mau;H and- Shao;Y. 
TITLE 	 The complete genome sequence of Escherichia toll• K-12. 
JOURNAL 	 Science 277 (5331), 1453-1474 (1997) 
COMMENT 
-Corresponding -GenBank -entry: U00096 (bases 4039 -120 to 4034661) 
legacy_attribute= CG.Site..NO. 189 
operon= rrsA gene 
isolate
-
name= MG1655 
EASE - COUNT - 	 389 a- 	 352 , c 	 487" g - 	 314 , u 	 2172 others* - 
ORIGIN 
1 ---------- ---------- ---------- ---AAAUUGA A-GAGUU-U- GA-U-CAU-G 
3B4L- -GUAGG.-GGA.-A:CCUG.>-C..GGU--UG.-GA.UCACCUCC U,A---------- ---------- 
3601 
--------- ---------- ---------- --------------------- 
3661. 
-- 	 -------- -------- -----•- 
readseq 
ExaEmAVasta 
>E.COlirnA3 .. 3714_ by . RNA:. 	 RNA.- 	 09-NOV-193,8,. 3714_-bases, 1504 checksum. 
------------------------------- --.AAAUUGAA-GAGUU-U- 
GA-U-CAU-G- 
GUAGG-GGA-A-CCUG--CGGU--UG-GAUCACCUCCUUA ---------- 
-------------------------------------------------- 
fasta2flat 
E.col im,k1fastaxonue€ted 
E.colirnA3 	 AAAUUGAAGAGUUUGAUCAUG_-GUAGGGGAACCUGCGGUUGGAUCACCLWCUUA 
Figure 4 
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Figure 10A-IOCT-he 	 prokaqofic phylogenetic tme in Nesvick Amnat. 
Figure 10.A 
<M-x.bark- er, \-MahwiosarciEm barkerisir. 227, DSIM 	 0 132 -16, 
str JFI DSM S- 64 (T)' : 0 16948 0.244-2 1 . 1<111.volcaiii> Halotcrax vo1canjistr- DS- 2 ATC-C -2960-5 (T) 0,036" 
:0.09112, (',-,env.SBA.Rt6> Santa Barbara Chamtel bacicdopl-,,.mA,1on DNA clonz SBARIG: 
<Tpl acidop> 	 NtT. 122-1132': 0 22004 ): 0.04-224 1: 0.10775 
Archactulobus fulgidnsstr. VC- 16 D&M 4304 (T)': 0.0407 . 	 05544, C,-,Mh lonnici Methanobacicrium 
fbanicicum DSM 13 IT: 0.0-1067 , '~,N-Tt.fcrvid l', Nlethanotherintis rcry 	 O 19024 ). 0 019 5  €1,.0947  
'<Tc cc Iu> Therr.nococcus cc ler sty, VU I 'i DS :t 24-1, 6 M' : 0.0098 1 1 : 0.05532 , C<mc.vanniel> MelhanOCOCCUS 
vaymi•ii sir. %x'33' :11.(12184 	 sir. JAL-1 DSM 266 1 (T)': 0.1614 
0.0(185 	 0.0280 	 1 > NR, thanopyms kandleri six. av- I '.) D&M 63 24 (T)': 0.0"~ 45 0.02701 , 
C<cnv,pJF12' 	 Volcano area of Yellowstou NP ("Black Pool") hot spring, UN"A clom pJ-P-^"7' -, 0,067 R,3 
((<cnv.SBAR12 ,  Sama Barbana Chanacl bactcrioplank-iort DNA clone SBARIT: 0,1046 
Volcano firea of'Yellowstmic NP ("Black Poch"') .licit spring DNA clone p3l?ff: 0. 2 852( ): 0.01 13,2, 
pendom, str. Hvv3 DSNA 24 5 (T)': 0.04404 ('<.Sul..icalda> Sulfalobus 
1 icidocaldadi£s sli , . , )8-3 ATCC 33909 MY: 0.04024 	 twax-' ~ OAW5 W02 06 
'M 64-9 
Thortnotom m ant j urm str. l'd SB8 DSN-I X109 (TY: 0, 0 100 1 '<Fer, I skmd> Fe.n., dobncwhum 
islaadic till) str. 11 -21 Ds'.Vl 5 " ':'3   (T)': 0. 1051 ): 0.2 +062  ((('<' N-1d 	 str. Lo ~J-tlovn. 2 
ATCC -1 5 1)4 x (T)': 0. 1 l40S , '<,D. radi odtw> Ddtloc Occus ra dioduraw, ATC C 50 7 3' : l£.1`.190' 0,08298 , 
C<C fvauranl - Chlwoflexm; a urann acvs slr. 3 - 10- il X C 2 X306 (TY: 0 19 ,70 , '<I i tic - rose u w> Th ermoi nic rob i w n 
wscum XrC C 2 502 (T)': 0,362 9' 0, 1 12 13 	 0,01165 	 Aq, la id la Acho tep] as i i ta faid laxv ii str. 
JAF: U4002 	 1134ATCC2558-( 11 :0,:x{). 74):O,OfC;16, 
ddbmockd,xibsp. delbru-ckii str. Calvcrt ATCC 9649 (T), 0,04809 ): 0,(?1852 ): 0.022 7 . ,1 •i;x1ow"C3> 
Listeria tumiocytogmics': 0,02418 ) : 0.0404 ,'--B,ccrcus4--  Biro lass corcus 1AM 12605 CF)': O,WM9 ): 0.0034, 
C<B.sabWis-- Bacillus subtfis sir. 16', 005051 	 Bacfflu siMumlwrmoplfflus -NICDO 1768 (TY 
0,05959): 0,0015 ): 6. 121 6-", '<E0,bark-cr:-  Ei baocrium barkori A C 25849 (r)': O,2YN7,S I ) : 0.0097 
 1 
('<C.qucy6cu', Clos[fidium quercicalum ATCC 2597 !4 (TY: OA35 I 	 146iobaciedual Chlurmll 
ATCC 35205 (T) : 0,1075): 0,01024 0,11118 3 , ("Tus'nucle"v" Fasohamt-ii.ink imdvmimsitbsp. kmOcalam 
ATCC'25596 (T)': 0,08593, 	 Sv-,cr)wmvccs a mbof acicyt&' : 0.06051 , f<Cor.xcros ~> 
xerosis X1"CC:'1,7'~ 	 (I . I t) .` j 1 ,5 	 BificlobacLUiLM). biridum ATCC 29521 . (T)' 
0,29842 	 Arkhrobacter globiformis sir. 1.68 DSM 20124 ji' : 0. 12 35'; 0.06797 0.007,48 
C 	 prok, 'ir ~ OjC P ~1~., Jog 
Docket 010AUS; USSN 10/0,57,270; Figntre 10A-10 	 m Nl~iwjck 
rorlylat, 
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0.3137 1) ;0,01731() : {). 0,51] , ('<,CJcpwm-- Clostddiumlptu-m ATCC 29065 JY: 016126, 
clostridium 	 EVI.3.6.t NCE10B h082': 6-0603 7 	 ATCC 
RubTivivax ,Aainosiis sm X1711 
-.2.1 ATCC 1 7011 (T)': [t,€17169 '<SpuvohE1a> Spil - ': luul volulans ATCC 19554 ('F)! 0,6666; 	 0,00-462, 
I, 	
-- is. L RcN,- ~ l)Lr,-ptlr> pd1odocyc Ills purpill-cus sit. 6770 DSM 10 'Y:0.04015) ~ 0.02165,' , N Yonorl>Nuisscria 
	
3 	 m I pil 	 0,1(P89):0,014 , 
AT(T 1363'7 (r)', 0,24098 ): 0.02299, C<Exoh' , Eschcrichlel COE [g,f:]W:::ITRB olacron!' I- 0,05',,C5 , '-Ts,aemgO-, 
P,seadanwuas wragluosi DSM 500 7 1 (T)': 0-63646 0,0524) - 0,0448§ '<AIm.vinosni-, Aflochmniauum 
vinfisum A`I'CC,[' 1'09 fTY: 0-0233 ): 0,048611 	 Halodiodospira baladiloTis su- , A ATCC 35916 ('T)' 
10_(15948 ): (.1)801 1) 	 Rhodospirillum rubrwn sit. ATH 1,1.11 S,1 AT CC i 11 -:0 T)' : 0.04904, 
Azs-brasi2> 	 tlraSj lensc str. Sp 7 NC IMB 11860 (T)': 0,30M ) : {),1) 1 34 , , (,('<Ric,prowax> Rickettsia 
prowazekii sm Breint Ai CC V 14 (T) (alpfia puiple bactcrium)': 0,14()6,`  Sp, ,,eapsW -, Splfillgyornona ~ 
capulat,,i , ATCC t 466(-, J)': 0, t 38.2 0,020(~,8 , (<Rhb,lvppmS> Rhimbilun lcgu utinosormn,1 A&T 	 cry: 
[ .015 -16 , ("-T3drjapOni -- 	 L""..'M 6]3S (T)', 	 Rhodomicrobitan 
vannidii gr. EY3-3.ATCC 5 1 194': 0,093 ): 0,04263 	 0,(Oi I? ): 0,03466 7 0,0677, 	 0,00 546, 
Mvxococcos xwolm& sit. DK 1622": 0,11263 '<,D5b. -posqRn--:, IX's tit fohn, wr po&wA 1 6 w .  ac 9 
DISN-VI M34 (T)': 0,19098 ): 0.01 154 . '<Dsv,dc&uW-- DcS'LlIfovibrio dcsillfuricans sub6p. dcstillbricans ATCC 
277-14' , x),{31 563 , ('<Bdc,swlpi> Bdollovibria stolph str. LW!2 ATCC 27052 (T)' : 0,05967 , (<C-ani-jt junS> 
CampYlobaclerjC"ijUliL subsp..jLjLB1j sin'FGH 9()1.1 A CC 43431': 11.111 5:3 1 	 INblinelb siiccino lwncs 
-ar, 60'~ W (FIX) ATCC 29543 (f)': 0.05551 '<1-Vb.pyIoi6> Helicubact;a pylQn ATC('43504- (TY: 0,023 ~, 1 s 
IMM): I  Ni 7 ! 	 0, 1,,'047 ): 0,01602 	 0,156 1.3 ): 0,01513 	 Treponufla pallidw -a sw-  
Nichols': 0,14543,'--Spj,sic.nos -> Spirochaeta iWnosttepw sir. ZI ATCC 25083 (T)': 0.0361-3, ): 0.03695 
'<Bov,burgd(P Borrelia buratorccri str, B3 t ATCC3521(1(1")' ; (). ':it {}4) (),Ilx849,'<Sl-t3.13atopli." "?pirochaaa 
hatophila str. RS1. ATCC 294778 (T)': 0,02473 	 Brachy-spira byedyscmeriac str, 13204 
ATC,C.31212 ! 1 0,43546 ), 0,04129, ('<,Lpr[jfliri:> 	 dfilli su,1055 ~ 0.07041 
inicaogwisstr. Kennewicki, scmNper ponlona': 0,169(121 	 0.05013 ): 0.01817 
cucdnog 	 -Acbf.capq 
	
iieszubsp. succinogenes sti. S811 ATCC 19169 (TY: 	 Acidobwerimn capmlatum 
'1285 	 ` o, 6 F : (3.21+7   99 0.0107 1 	 0.0094 , ((((('<Syn 63 0 Sy nchococc us Sp. P CC 0304 ~ ': 0. 1 	 '<N - unuscr- 
ws 
chlovnpin,st l : 0 145,'<O1sHi3t C,,- Olimhodkclls lulcus ("wamcnopi1c) -- chloroplas!'' 0.3 323 	 000491 ): [1.1112, 
'<Utb.viotac' , Glocobacta violaccus PCC741-1'; 0,072"9
.
) 0.01 171 ., 	 K"vlount cooE-Iha t-c"noll 
(Brisbane, Ausiratial 5-Mciu depth soil DNA done NIC 18' 0.01409 , (<Chd psiva-, Chlam 
'
ph vdoila pslmaci str. 
fflC ATCC VR-125 (T)': 	 Pirellula slalcyi i1'TCC )7 :' 	 0 ~ 77 ~ .34247 	 [).2 . £193 ): O.t 1 2 1 
0.03 1,;8, 	 chlorob; EUM limicola SEE ' . 8127': 6. 13t9, ('<Tm.nbpswa' TivrmmAcron kipsum ATCC 
Dotket 010AUS, 1;"SSN 10/057,270, Figure JOA-40C Tho 	 prokaryotic ph -00,gmefle trey, iii N.Ncvvick 
U.S. Patent 	 Jul. 3, 2012 	 Sheet 13 of 15 	 US 8,214,153 BI 
43~ 	 V7 0.013-2  
Filyu.1-C IOC 
PersiookmctprdifMumnoot: Lewin UK8-1 ATCC23lxO '0,00585.(I<5ep,gmmdi> Syp,wm9kagrnndisATCCZ}z1S(T)' ~ 
0.02768 ' (^<Rxcaoada^qexihnrtercanodensisATCC29591(T)' ~ 0.03254,<(`x8axfmgi[/8actemWeofr«gifiuAJ{C 
25285(T) ~ 0.048I6 ' `/Pw/unocw|>P,evueUa,umioicolusubsp.ruminiom|aAT{C19I89[p': 0.20539) ~ 0.02821 ' 
('<CV,IVdo>cytopha8u|it/camzWm-21mzC 23178(T)' ~ 0.143s5''^Emb.bnovi2>smuedobacte brevis A7Cc 
14234^/0,091}) ~ 035994):0.12199)'033292)'0.4/588)`014622}:0.18424)/0388/8):030469): 
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5577- 
Acidocella facilis [Acc.faci12] * 
5576 	 Acidiphilium.angustum [Acdp.angu2] F— 5565 
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5575 
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5573 
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	 COPYRIGHT 
RESULTS CD APPENDIX 
Certain results obtained by the invention are set forth on the 
CD which is enclosed as a part of the application under 37 
Code of Federal Regulations Section 1.58. 
PROGRAM CODE APPENDIX 
Contained herein is material that is subject to international 
copyright protection. The copyright owner has no objection to 
the facsimile reproduction of the patent disclosure by any 
25 person as it appears in the Patent and Trademark files or 
records, but otherwise reserves all rights to the copyright 
whatsoever. 
The computer programs and subroutines of the invention 
are set forth on the CD, which is enclosed as a part of the 30 
application under 37 Code of Federal Regulations Section 	 I. Field of the Invention 
1.96. 	 The present invention relates to the general field if bio- 
ASCII, MS Windows; 	 chemical assays and separations, and to apparatus for their 
practice, generally classified in U.S. Patent Class 435/6. 
35 	 II. Description of the Prior Art 
Unlike multicellular organisms, bacteria and simple 
eukaryotic microorganisms have very limited morphological 
diversity and typically do not leave a significant fossil record. 
It therefore was initially very difficult to develop a classifica- 
40 tion system, which reflects actual genetic relationship. 
Instead, classic bacterial taxonomic methods, such as mor-
phology and carbon source utilization were used to classify 
bacteria in a deterministic way. The goal was to develop a 
hierarchy of tests that ultimately could reproducibly assign a 
45 consistent name to an unknown isolate. When organisms gave 
very similar results on the various tests they would ultimately 
be assigned to the same species regardless of actual genetic 
relationship. Thus, organisms were sometimes grouped 
together that were fundamentally very different. 
50 	 This situation changed dramatically in the 1970's due to 
the pioneering work of Carl Woese and his colleagues. In 
order to obtain a genotypic classification, methods based on 
molecular sequence analysis of ribosomal RNA (rRNA) were 
developed. The rRNAs offered the advantage of being found 
55 in all organisms andthe equivalent molecules couldbe readily 
isolated andpurified from essentially any organism. The large 
ribosomal RNAs vary in length depending on the organism 
and therefore have different names, e.g. 16S rRNA, 18S 
rRNA etc, depending on the organism under consideration. 
6o To avoid this difficulty, the terminology small subunit RNA 
(SSU RNA) and large subunit RNA (LSU RNA) is used to 
specify any of the RNAS belonging to each class. Among the 
rRNAs, 5S rRNA with approximately 120 nucleotides was 
thought to be too short to be useful and the LSU RNA, (23S 
65 rRNA in bacteria), would have been far more difficult to work 
with. Attention therefore focused on the SSU RNA (16S 
rRNA in bacteria). 16S rRNA is a major component of the 
BACKGROUND OF THE INVENTION 
Name Size Type Created Time 
Programs File Folder Jan. 24, 2002 
6:02 PM 
1-> calc_node_values 6 KB Text Jan. 23, 2002 
Document 6:35 PM 
1-> fasta2flat 2 KB Text Jan. 23, 2002 
Document 6:35 PM 
1-> group_ node_ lister 4 KB Text Jan. 23, 2002 
Document 6:35 PM 
1-> hybridize 3 KB Text Jan. 23, 2002 
Document 6:35 PM 
1-> list_hit_branch_nodes 5 KB Text Jan. 23, 2002 
Document 6:35 PM 
1-> probes_ hash_ table—generator 6 KB Text Jan. 23, 2002 
Document 6:35 PM 
1-> result printer 5 KB Text Jan. 23, 2002 
Document 6:35 PM 
1-> result_ printer_ 6 KB Text Jan. 23, 2002 
Document 6:35 PM 
1-> select_seq 3 KB Text Jan. 23, 2002 
Document 6:35 PM 
1-> seq_classifier 2 KB Text Jan. 23, 2002 
Document 6:35 PM 
> tree parser 16 KB Text Jan. 23, 2002 
Document 6:35 PM 
signature_ sequences File Folder Jan. 24, 2002 
6:02 PM 
1-> 10_mers.txt 12,552 KB Text Jan. 23, 2002 
Document 6:26 PM 
1-> 11_mers.txt 13.611 KB Text Jan. 23, 2002 
Document 6:28 PM 
1-> 12 mers.txt 14,636 KB Text Jan. 23, 2002 
Document 6:28 PM 
1-> 13_mers.txt 15,690 KB Text Jan. 23, 2002 
Document 6:30 PM 
1-> 15_mers.txt 17,790 KB Text Jan. 23, 2002 
Document 6:31 PM 
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bacterial small ribosomal subunit. It consists of approxi- 	 applied for patents (U.S. Pat. No. 4,851,330 granted 25 Jul. 
mately 1,550 ribonucleotides in Escherichia coli and has an 	 1989 and U.S. Pat. No. 5,288,611 granted Feb. 22, 1994) the 
intricate secondary structure featuring extensive intrachain 	 essence of which is that a nucleic acid probe that is comple- 
base pairing. The detailed three-dimensional folding of 16S 	 mentary to the rRNA of a specific target can be used to detect 
rRNA in the Thermus aquaticus 30S ribosomal subunit has 5 the presence of that target. This core approach has been 
recently been determined by X-ray crystallography. As a 	 widely used in microbial identification with probes usually 
major component of the ribosome, 16S rRNA interacts with 	 being devised by sequence comparison rather than Kohne's 
23S rRNA to establish the overall geometry of the ribosome 	 preferred embodiment that was subtractive hybridization. 
and is directly involved in the initiation of protein biosynthe- 	 Several commercial products rely on this approach. 
sis by ribosomes. 	 10 	 The invention described here provides a novel approach for 
When Woese first began using 16S rRNA in his evolution- 	 rapidly determining the genetic affinity of organisms in test 
ary studies it was not technically feasible to sequence the 	 sample. The invention's methodology is far more general 
entire RNA. Therefore a characterization approach was 	 than the specifically targeted tests of the Kohne approach, and 
developed (Uchida et al., 1974) in which the 16S rRNA was 	 faster and more convenient than detailed sequencing of the 
fragmented by the nuclease, ribonuclease T i . This enzyme 15 rRNAs or their encoding DNA. The method of this invention 
cleaves the RNA at guanosine (G) residues and thereby 	 is currently most readily utilized with 16S rRNA sequence 
reduced the RNA to a collection of fragments of various 	 data but can be adapted to other data sets such as rRNA 
lengths with a single terminal G. The non-G portion of the 	 spacers, RNAse P RNA, genomic DNA or RNA of viruses, 
fragment was then sequenced. The lists of all such fragments 	 etc. One begins by defining microbial groups within a phylo- 
obtained from a single RNA was referred to as a catalog. 20 genetic tree that includes the organism range of interest, e.g. 
Catalogs of ribonuclease T, fragments from 16S rRNAs iso- 	 all bacteria for example. Then a set of characteristic oligo- 
lated from a variety of organisms were compared to one 	 nucleotides, each of which identifies a group in the phyloge- 
another and cluster analysis was used to construct a tree of 	 netic tree, is determined according to a newly developed 
relationship between the various bacteria (Fox et al., 1977). 	 algorithm of the invention. This set of signature oligonucle- 
By 1980, enough data of this type had accumulated that it was 25 otides is utilized in a hybridization experiment, e.g. a DNA 
possible to construct the first trees that seriously attempted to 	 microarray, the results of which are then used to quickly 
identify the actual historical relationships between the vari- 	 identify the phylogenetic neighborhood of a problematic bac- 
ous types of bacteria (Fox et al., 1980; Woese, 1987). 	 terium, or other microorganism. These hybridization experi- 
Later, as sequencing technology was improved, it became 	 ments can be miniaturized so that minimally trained person- 
possible to sequence and compare entire 16S rRNAs. 	 30 nel can readily conduct them in difficult environments. The 
In an effort to better understand the tree produced by clus- 	 set of signature oligonucleotides can be updated and rede- 
ter analysis, an alternative means of examining relationships 	 signed as our knowledge of the true genetic affinity between 
known as "signature analysis" was developed (Woese et al., 	 known organisms improves. In many cases, the hybridization 
1980). It was observed that certain of the ribonuclease T, 	 array will be able to determine the genetic affinity of multiple 
fragments were only found in a subset of the 16S rRNA 35 organisms in a sample in one experiment. If the organism 
catalogs. Frequently there was more than one such sequence 	 turns out to be a previously known organism, its identity can 
that was uniquely found in the same group of organisms. 	 be determined to the species level if suitable signature oligo- 
Thus, the term "signature" was introduced as follows: "a set 	 nucleotides are included in the hybridization. Under some 
of oligonucleotides that is characteristic of (unique to) a 	 circumstances, the signature sequences can also be used in 
group of organisms defines that group and is a "signature" for 40 assays which detection does not rely on hybridization. 
the group". These signatures suggested that there was a rela- 
tionship between the organisms in the group and so the tree 	 Problem Solved by the Invention 
was examined to see if the tree-generating algorithm had in 
fact found the expected relationship. 	 The Kohne patents (below) teach methods to utilize probes 
This process of checking the reasonableness of trees pro-  45 to detect specific predetermined organisms or groups of 
duced from the cataloging data was employed on several 	 organisms. Thus, the '611 patent teaches us how to determine 
occasions (Woese et al., 1980; Woese et al., 1984; McGill et 	 if a particular species of organism is or is not present in a test 
al., 1986). In its final rendition, (McGill et al., 1986) the 	 sample. The '330 patent teaches us how to detect specific 
notion of a signature quality index that couldbe calculated for 	 groups of organisms as well as individual organisms. It is 
every individual RNAse T, oligonucleotide was introduced as 50 somewhat limited, however, in that the probes under this 
a means of formalizing the extent to which there was or was 	 invention are obtained by selection; i.e. subtractive hybrid- 
not a signature for each branch in the tree. 	 ization. Others have subsequently demonstrated the ability to 
Today, comparison of 16S rRNA sequences is widely used 
	
detect specific groups using probes based on sequence com- 
to establish the genetic relationship between bacteria. A typi- 	 parisons. 
cal approach is to amplify and sequence 16S rDNA from 55 	 It is implicit in all these prior art references that one knows 
various prokaryotic organisms. The resulting sequences are 	 what one is looking for. Thus, a prior art test can be specifi- 
aligned with other 16S rRNA sequences and an appropriate 	 cally designed for detecting Legionella. However, this is not 
method, e.g. maximum likelihood, is used to construct a tree 	 always what is needed, e.g. a quick response might be neces- 
that reflects likely historical relationships. Several public 	 sary to respond to an outbreak of a previously unknown 
databases exist containing complete and partial small subunit 60 transmissible microbial disease. Perhaps even more to the 
rRNA sequences. For example, release 8 of the RDP database 	 point in this day and age, a terrorist could bioengineer a 
(Maidak et al., 2000) includes data far the small subunit RNA 	 normally harmless organism to carry a gene that results in 
from over 16,000 bacteria, eukaryotes, plastids and mito- 	 production of a deadly toxin. The resulting organism would 
chondria. 	 have properties not normally associated with the bacterium 
As Woese's work became well known it began to be appre-  65 that carries the toxin gene. Indeed, the organism itself might 
ciated that RNA might be useful in detecting the presence of 
	
be from a previously unknown genus. Similarly, there are 
a target organism in a test sample. Thus, in 1980 Kohne 	 instances where work is done in remote locations such as the 
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Antarctic or on the International Space Station where one has 
extremely limited diagnostic capability available. Even in 
standard medical practice microbial identification is need-
lessly cumbersome in that many alternative specialized tests 
are now used to identify the presence of the various known 
pathogens. In all of these cases the ability to genetically 
characterize and hence identify what organisms or viruses are 
present in a test sample with a single universal test system 
would be invaluable. The invention provides this badly 
needed solution in a very general way. 
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10 	 SUMMARY OF THE INVENTION 
Applicants' method is summarized as follows: 
A. Establish or otherwise obtain a nucleic acid sequence 
15 database of the equivalent nucleic acid from a variety of 
organisms. It is best to quality control the database; selecting 
sequences, which are complete and lack unknown segments 
in the region of interest, discarding the rest. Any of a variety 
of nucleic acid sequences is potentially useful. At present the 
20 substantial amount of sequence information available for 
rRNAs, especially the SSU rRNA (i.e. 16S rRNA in bacteria) 
makes that molecule an excellent choice for bacteria and 
eukaryotic microorganisms. In the case of viruses the most 
promising source of information is currently the sequence of 
25 the genomic DNA or RNA. 
B. Obtain or develop a bifurcating node phylogenetic tree 
that substantially reflects the genetic relationships between 
the organisms or viruses whose sequences are included in the 
nucleic acid sequence database that is to be used. 
30 	 C. Choose a smallest sequence length of interest for the 
characteristic sequence, which will be sought. This length 
will differ depending in on the length of the nucleic acid 
molecule or region being examined, the number of sequences 
in the dataset and various constraints by the experimental 
35 systems that will be used. 
D. Test all possible sequences of this length N against the 
entries in the nucleic acid sequence database that is being 
used in conjunction with the tree. A signature quality function 
such as Qs is calculated for every possible sequence of length 
4o N at eachnode inthe tree. It is preferable and computationally 
efficient to only calculate the Qs value for test sequences of 
length N that occur at least twice in the database. Those test 
sequences that never occur are not signature sequences. Test 
sequences that occur once are perfect signature sequences of 
45 the particular organism or virus from which the nucleic acid 
was obtained. The signature quality function can be defined in 
a variety of ways but should be constructed so as to determine 
the extent to which a test sequence of length N is found in all 
the organisms in the database belonging to the set of 
50 sequences represented by a node in the tree and not found 
elsewhere. A particular test sequence is determined to be a 
perfect signature of the organisms represented by a particular 
bifurcation node on the phylogenetic tree if all the nucleic 
acid sequences represented by that node contain the sequence 
55 and the sequence is not found in any nucleic acid sequence not 
represented by that node. A value Qs between zero (no sig-
nature value) and one (perfect signature) is obtained for each 
test sequence at each node. 
E. Retain as signature sequences those test sequences hav- 
60 ing QS above some criterion. A given node may encompass 
many signature sequences. Likewise, a particular test 
sequence can be a signature encompassed by more than one 
node, though frequently with differing values of Qs. This 
reflects the child, parent, grandparent, etc. relationship 
65 between bifurcation nodes on a phylogenetic tree. 
F. Optionally, Repeat the steps D and E for sequences of the 
desired length (e.g., 7mers, then 8mers, etc). 
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G. The signature sequences permit the design of hybrid- 	 FIG. 11 shows a graphic view of the representative 
ization probes for use in an assay. A typical assay can employ 	 prokaryotic phylogenetic tree. 
a plurality of such signature probes representing at least 50%, 	 FIG. 12 A local region of the representative tree following 
and typically more, of the nodes in the applicable phyloge- 	 trimming from 38 to 12 sequences. The branch numbers in the 
netic tree. The resulting hybridization will allow the identifi-  5 representative tree are labeled in the picture and can be cor- 
cation of the organism's genetic affinity without the necessity 	 related with the results given in Table F. The complete repre- 
ofprior knowledge of what it wouldbe. It is contemplated that 	 sentative tree is given in Newick format in FIG. 10 and shown 
this invention can allow the development of a single test 	 in graphical form on the CD that is part of this application 
system that can be used to identify a wide variety of organ- 	 Table A illustrates by example certain information, which 
isms. 	 10 is on the CD that is part of this application. The table illus- 
H. Once available, the signature sequences can be used in 	 trates for test sequences of length 15 the five best signature 
other ways. For example, it is preferable to detect the pres- 	 quality scores and the nodes they are associated with in the 
ence of specific signature sequences in a sample using mass 	 phylogenetic tree. 
spectrometry. It is also preferable to use signature sequences 	 Complete lists of this type are on the CD for a several 
to design PCR primers for a variety of applications. 	 15 different sequence lengths. 
In abstract form the invention may be described as follows: 	 Table B illustrates by example certain information, which 
Selecting which sub-sequences in a database of nucleic 	 is on the CD that is part of this application. The table illus- 
acid such as 16S rRNA are highly characteristic of particular 	 trates signature sequences of length 12 that are completely 
groupings of bacteria, microorganisms, fungi, etc. on a sub- 	 unique to the organisms that is indicated. 
stantially phylogenetic tree. The invention is also applicable 20 	 Table C shows the subsystems of the programs used and 
to viruses comprising viral genomic RNA or DNA. A cata- 	 their functions and components. 
logue of highly characteristic signature sequences identified 
	
Table D shows the numbers of possible oligonucleotides of 
by this method is assembled to establish the genetic identity 	 different lengths 
of an unknown organism. The signature sequences are used to 	 Table E shows a the number of signature sequences that 
design nucleic acid hybridization probes that include the 25 were found at various quality levels as a function of length. 
characteristic sequence or its complement, or are derived Table F shows the preferred parameters for the invention. 
from one or more characteristic sequences. A plurality of 
these signature sequences is used in hybridization to deter- 	 Utility of the Invention 
mine the phylogenetic tree position of the organism(s) in a 
sample. If the target organism is represented in the original 30 	 The invention can identify the genetic grouping an 
sequence database and the signature sequences can identify it 	 unknown organism belongs to even if no perfect match is 
to the species or possibly subspecies level. Oligonucleotide 	 found for the organism of interest, (the "target"). The inven- 
arrays of many probes are especially preferred. A hybridiza- 	 tion designs a set of probes that allows one to approximately 
tion signal can comprise fluorescence, chemiluminescence, 	 position any target organism on a tree that displays the genetic 
or isotopic labeling, etc.; or sequences in a sample can be 35 relationship between the various organisms. With the inven- 
detected by direct means, e.g. mass spectrometry. The meth- 	 tion, it is not necessary to know what organism or group of 
od's characteristic sequences can also be used to design spe- 	 organisms one is looking for nor is it necessary that it even be 
cific PCR primers. The method uniquely identifies the phy- 	 previously known to science. Ultimately, even if nothing 
logenetic affinity of an unknown organism without requiring 	 matches, the invention nonetheless gives useful information. 
prior knowledge of what is present in the sample. Even if the 4o For example, it might be learned that the unknown organism 
organism has not been previously encountered, the method 
	 belongs to the group of enteric bacteria but is not any of the 
still provides useful information about which phylogenetic 	 known species. Using the invention, it is straightforward to 
tree bifurcation nodes encompass the organism. 	 generate a clear file withthe five best signature quality values; 
in the format of TableA. The five best signature quality scores 
DETAILED DESCRIPTION OF INVENTION 	 45 for the indicated sequence are listed with the specific node in 
the phylogenetic tree. 
Brief Description of the Several Views of the Drawings 	 Unanticipated problems involving microorganisms occur 
FIG. 1 shows schematically the bi-directional binary tree 	 in a variety of settings including space flight, medicine, 
structure. 	 indoor air quality, bioweapons of mass destruction, epidem- 
FIG. 2 shows schematically the structure of the composite 50 ics, etc. It would be of value to have a diagnostic system that 
hash of the oligonucleotides. 	 could readily identify what microorganism is present regard- 
FIG. 3 shows schematically the flow chart of the principal 
	
less of prior expectations of what might be found, so as to 
programs. 	 facilitate a rapid assessment of what is occurring prior to 
FIG. 4 shows schematically how Subsystem I converts the 	 choosing of countermeasures. It is especially essential to 
format of the sequence file. 	 55 determine the genetic identity of the organism that is causing 
FIG. 5 shows schematically a phylogenetic tree and its 	 the problem as closely as possible, since this will clarify 
corresponding Newick format presentation. 	 where the organism came from, what treatments are likely to 
FIG. 6 shows schematically the tree file in Newick format 	 be effective, etc. 
is parsed in a stepwise and bottom-up manner 	 Fortunately, each 16S rRNA sequence contains short sub- 
FIG. 7 shows schematically the trimming is stepwise and 60 sequences that are widely conserved throughout the dataset 
topology-conserving 	 and despite the fact that there are now over 16,000 publicly 
FIG. 8 shows schematically the composite hash of the 	 available sequences, there are still large numbers of other 
oligonucleotides is built from the 16S rRNA sequences 	 sub-sequences, which are totally unique to, and hence char- 
FIG. 9 shows schematically how the number of oligonucle- 	 acteristic of, a particular species or various groups of species 
otides and their respective lengths length are related. 	 65 that can be identified by methods of the invention. Surpris- 
FIG. 10 shows the representative prokaryotic phylogenetic 	 ingly, this pattern of sequence conservation is so strong that it 
tree in Newick format. 	 is possible to design specific oligonucleotide hybridization 
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probes that can distinguish individual organisms, and group-
ings of organisms in a tree of relationship defined by 16S 
rRNA. Once an appropriate set of target signature sequences 
have been identified for a desired assay, appropriate probes 
can be designed. Although it is anticipated that probes based 
on the signature sequences will be used directly, in some 
applications, the probes can be modified before use. For 
example, a "wildcard" base such as inosine might be used to 
extend or even modify the specificity of a probe. Moreover, 
two nearby probes might be combined to make a larger probe. 
Any of a variety of formats can be used to implement the 
assays. Thus, the final analysis system may utilize PCR-
amplified nucleic acids or, because rRNAs are typically 
present in many thousands of copies per cell, just the sample 
RNA alone. A variety of detection systems can be used, 
comprising fluorescence, chemiluminescence and isotopic 
detection. The resulting assay is highly compatible with 
hybridization array technology (DNA microarrays), which 
will allow the simultaneous assay of all the nodes in the 
underlying tree in one experiment. Thus, it is possible to 
replace many tests with just one. It is inherent in the prior art 
that only predetermined microorganisms or groups of micro-
organisms will be detected. This reflects the fact that prior art 
assays are based on prior identification of specific probes for 
the intended application. It is widely believed that a microbial 
detection system cannot be designed without prior knowl-
edge of what is to be detected. The invention described here 
implements a novel approach to assay design that overcomes 
this problem. 
Scientific Basis of the Invention 
Although the invention is not to be limited by any theory or 
by the way in which the invention was achieved, the following 
may be helpful in understanding the invention. An extremely 
effective approach to determining genetic relatedness among 
bacteria is to amplify and sequence their 16S rRNA genes 
(Fox et al., 1980; Woese, 1987). The resulting sequences are 
aligned with other 16S rRNA sequences and an appropriate 
method, e.g. maximum likelihood, is used to construct a 
phylogenetic tree. This process is reasonably fast, very accu-
rate and facilitated by programs and data available via the 
Internet at the Ribosomal Database Project (RDP) web site 
http://www.cme.msu.edu/RDP/html/index.html)  (Maidak et 
al., 2000). Many thousands of 16S rRNA sequences, repre-
senting essentially all known genera of bacteria, are now 
available in the RDP and other ribosomal RNA databases. 
Therefore, when a new isolate of uncertain affiliation is found 
here on Earth, its genetic identity can be inferred from its 
placement in the 16S rRNA phylogenetic tree. 
It was observed early on in the 1 6S rRNA literature that 
there were in fact many characteristic ribonuclease TI (a 
subset of all possible oligonucleotides that consists only of 
those which end in G and contain no internal G) "signature" 
oligonucleotides (Woese et al., 1980;). The existence of such 
signature oligonucleotides in a set of 16S rRNA sequences 
actually reflects the fact that certain individual positions have 
a particular value (i.e. A, C, G or U) in all organisms belong-
ing to a particular cluster and a different value for organisms 
which do not belong to the cluster. The phylogenetic breadth 
of the cluster encompassed is different for each signature 
position and the signatures are typically somewhat noisy in 
that the characteristic nucleotide is absent in some organisms 
that belong to the cluster of interest and present in some 
organisms that are outside the cluster. The information that is 
carried by these very informative sites is nevertheless pre-
cisely what underlies the success of standard algorithms that 
construct phylogenetic trees. 
10 
In order to quantify this information, a signature quality 
index, which ranges from 0 (no meaningful signature) to 1 
(perfect signature) was developed for use with the ribonu-
clease T1 oligonucleotides (McGill et al., 1986). Such an 
5 index allows the quantitative characterization of the utility of 
any oligonucleotide in determining if an unknown organism 
belongs to any particular genetic grouping in a particular tree 
of genetic relatedness. In order to implement the invention it 
was necessary to modify the signature quality function for use 
10 
with complete sequence data. The signature quality index 
used is of the following type: 
Q,-N-(1 -0f) 	 (1) 
15 where Q is a measure of signature quality, rf is the frequency 
of the signature sequence within the group under consider-
ation, and OF, is the frequency of the signature sequence 
outside the group of interest. The frequencies are based on the 
20 number of sequences in the dataset that a particular oligo-
nucleotide matches and the resulting function again varies 
from 0 (no meaningful signature) to 1 (perfect signature). 
To illustrate this function, consider a particular heptamer, 
which is found in 50 distinct sequences. If 40 of these occur- 
25 rences are in a single taxonomic cluster, which contains 50 
members and the remaining 10 occurrences are scattered 
among the remaining sequences the resulting value of Q is 
0.64. Finally, the user of the invention needs to understand 
that when members of a sequence cluster share an oligonucle- 
30 otide which is not found in non-members of the cluster (e.g. 
when Q is high) the oligonucleotide in question will almost 
always be found to occur in the equivalent place in all the 16S 
rRNAs that have it. This reflects the fact that useful signature 
35 sequences are phylogenetically conserved at various levels of 
genetic relationship. This is not obvious because it initially 
seems very counterintuitive. It is, however, the reason high 
quality signature oligonucleotides exist. If this were not the 
case the various oligonucleotides would be randomly scat- 
40 tered throughout the various sequences and high values of Q 
would be uncommon and not predictive of what would be 
found in sequences that were not yet known. 
It is also important to realize that there are many alternative 
ways in which the signature quality function, Q, is defined. 
45 One for example might take the logarithm of values or use 
values of 1-Q. More to the point one could square the first 
factor in Equation 1 to give more weight on any false nega-
tives or cube the second factor to strongly penalize false 
50 
positives. 
What size of oligonucleotides will give useful signature 
information? In the case of shorter small sequences, the 
equivalence of position is overshadowed for small oligo-
nucleotides such as the 4,096 (4 6) different hexamers, many 
55 of which can be expected to occur by random chance among 
the 1,500 hexamers that one expects to find in a single 16S 
rRNA sequence. Thus, the heptamers (4'=16,384 in total) 
represent the smallest sequence length that is likely to pro-
duce meaningful signature information. On the opposite side, 
60 large oligonucleotides tend to be unique to individual organ-
isms. That is to say, as oligonucleotide size increases, a larger 
portion of the signatures will be for leaf nodes, e.g. small 
numbers of closely related organisms and a decreasing per-
centagewill signify internal nodes. Based on prior experience 
65 with 16S rRNA ribonuclease TI oligonucleotides, it is likely 
that sequences larger than length 15 will mainly have utility 
for leaf nodes. 
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Design and Implementations 
Programming Language 
Except the first program readseq , which is preinstalled as a 
binary executable , all other programs developed for this 
project were written in Perl. 
Perl is afreely available, non-proprietary , open-sourcepro-
gramming language. Thus , programs written in Perl will not 
be affected by possible future changes in the license of the 
language compiler/interpreter . Perl is also a very high-level 
language for general purposes . It has 4 function points per 
100 lines of code, compared with 0.8 for C and 2 for C++. This 
means that software development in Perl is generally much 
faster than that in most other programming languages. Perl is 
especially efficient in dealing with text , which makes it an 
appropriate choice for manipulating genetic sequences. In 
addition , Perl's excellent built-in data structures , automatic 
garbage collection , and almost unrivalled portability also 
make it more attractive. 
More information on Perl and its newest release can be 
found at the Perl web site: http://www.perl.com.2.2  Data 
structures. 
All Perl built-in data structures , namely scalar, array, and 
hash, are used in this invention . Because of the complexity of 
the data presentations, more sophisticated data structures 
such as bi-directional binary tree and composite hash , are also 
used. 
Given the characteristic structure of the phylogenetic tree, 
it was natural to represent it as a binary tree in the program. In 
this case the tree structure is special in that it is bi-directional. 
The parent tree node has a pointer to each of its two child tree 
nodes and the child tree node also has a pointer back to its 
parent tree node (FIG. 1). This unusual tree structure is 
required to facilitate the signature quality index value calcu-
lation at each branch tree node (excluding the tree root an all 
the leaf nodes). 
Each leaf tree node has five data fields: "shortName", 
"fullName", "leafNumber", "isValid", and "isMatched" 
(FIG. 1). The first two fields hold the abbreviated name and 
the full name of the prokaryote. leafNumber records the 
sequentially assigned number of the leaf node in the tree. The 
last two are Boolean variables used mainly for calculation 
purposes. Each branch tree node has four data fields: "node-
Number", "numLeaves", "numValidLeaves", and "num-
MatchedLeaves" (FIG. 1). The first field records the sequen-
tially assigned number of the branch tree node. The other 
fields record the number of leaves, "valid" leaves, and 
"matched" leaves descended from this branch tree node 
respectively. 
FIG. 1 shows the bi-directional binary tree structure with 
three leaf nodes . Note that a parent node has two pointers to its 
child nodes and each child node has a pointer back to its 
parent. 
A composite hash was used to store all the oligonucleotides 
of a specific length derived from a dataset of the prokaryotic 
16S rRNA sequences and their related information. The 
"infrastructure" of this composite hash was implemented 
with Perl's built-in hash. Because of the complexity of the 
information on each oligonucleotide , an anonymous hash 
data structure was heavily used to accomplish the task. 
In Perl, a hash is composed of the unique keys and their 
corresponding values. The keys of the outmost layer of the 
composite hash are the sequences of the oligonucleotides and 
the value of each key is an anonymous hash which has three 
keys "matchingTimes", "matchingOrg", and "treeNode-
Values". The value of "matchingTimes" counts how many 
times the oligonucleotide occurs in the 16S rRNA sequence 
12 
dataset. The value of "matchedOrg" is the set of the names the 
organisms whose 16S rRNA sequences are matched by this 
oligonucleotide . Because of the special nature of the hash 
that is, its keys must be unique the set is also implemented 
5 with an anonymous hash, whose keys are the names of the 
matched organisms and the corresponding values are set to 
"undef'. The value of "treeNodeValues" records the five 
highest quality index values at the branch nodes. This is 
implemented with an anonymous hash whose keys are the 
io branch tree node numbers and the corresponding values are 
the quality index values (FIG. 2). 
FIG. 2 shows the elaborate structure of the composite hash 
used in the program . Only two entries are shown in this figure. 
A hash is represented by a table and the keys are shaded. o 
15 denotes the data type "undef' in Perl. The data in this hash are 
for elucidatory purposes only. 
Algorithm: 
The signature quality index measures how well an oligo-
nucleotide (probe) signifies ataxonomic group of prokaryotic 
20 organisms in the phylogenetic tree. Thus, the index qualita-
tively measures the "quality " of the signature sequences and 
ranges from 0 (no meaningful signature ) to 1 (perfect signa-
ture). The index can be mathematically expressed as: 
25 	
Q,- (`f)X(1 -°f) 	 (1) 
where Q is a measure of signature quality, rf is the frequency 
of the signature sequence within the group under consider-
ation , and °f is the frequency of the signature sequence 
outside the group of interest. 
30 Given a defined group of prokaryotes, rf and °f can be 
empirically described as: 
1f -N~n~,z 	 (2) 
(3) 
35 where NM is the number of probe-matched prokaryotes in the 
entire tree, NAM  is the number of probe-matched prokaryotes 
in the group of interest, and NGT is the number of prokaryotes 
in the group under consideration. Interpolate equation (1) 
40 with equations (2) and (3), we have: 
Q, = (NcM / Ncr) X 0 - (NM - NcM) l NM) 	 (4) 
_ (NcM) l (Ncr X NM ) 
45 
Preferably, the invention uses equation (4) to calculate the 
signature quality index Q and in order to do so during run 
time it keeps tracking NAM  Nor, and Nmof every oligonucle- 
50 otide of a specific length at every internal tree node. Since 
equation (4) is derived from equations (1), (2), and (3), if any 
one of these three equations changes, which may occur based 
on new insight into how characteristic signatures occur and 
are distributed in 16S rRNA sequences, equation (4) will 
55 change accordingly. This great flexibility provides system 
improvements that are included in the invention. 
System Implementation 
The identification system used to find characteristic oligo-
nucleotides in the 16S rRNA sequence dataset consists of the 
60 following twelve principal programs and several auxiliary 
programs, all provided on the CD enclosed with the applica-
tion. 
Principal programs: 
readseq (preinstalled program, not written by the author) 
65 	 fasta2flat 
seq_classifier 
tree parser 
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select _seq 	 positions in the sequences that have not been fully determined 
probe—hash—table—generator 	 (i.e. if any position is noted by a letter other than A, U, G, and 
calc_node_value 	 Q. Program select _seq filtered out these problematic 
result printer & result printer 	 "invalid" sequences and retained 1,921 "valid" sequences 
group_node_lister 	 5 that are fully determined and longer than 1,400 nt. 
list—hit—branch—nodes 	 The comprehensive prokaryotic phylogenetic tree based 
hybridize 	 upon 16S rRNA sequence in Newick format was obtained 
Auxiliary programs: 	 from the RDP web site. The Newick format for representing 
node selector 	 trees in computer-readable form makes use of the correspon- 
tree2newick 	 io dence between trees and nested parentheses, noticed in 1857 
FIG. 3 gives a panoramic view of the relationship among 	 by the famous English mathematician Arthur Cayley. A 
the principal programs and the data flow in this system. This 	 simple exemplary tree and its corresponding Newick format 
oligonucleotide identification system can be roughly divided 	 are depicted in FIG. 5. 
into four functionally different subsystems, which in turn 	 As shown in FIG. 5, the invention can form a phylogenetic 
carry out sequence file format conversion, internal data struc-  15 tree and its corresponding Newick format presentation. 
ture preparation, function value calculation, and result pre- 	 The tree in Newick format ends with a semicolon. Interior 
sentation respectively (Table A). 	 (branch) nodes are represented by a pair of matched paren- 
The unaligned prokaryotic 16S rRNA sequences were 	 theses. Between them are representations of the nodes that are 
downloaded from the RDP in Genbank format. The 16S 
	
immediately descended from that node, separated by com- 
rRNA sequences are from those prokaryotic organisms that 20 mas. The tree in FIG. 7 has six leaf nodes at the tips (A, B, C, 
appear in the comprehensive prokaryotic phylogenetic tree. 	 D, E, and F) and five branch nodes inside (the root node and 
Genbank format is the standard format for annotated nucleic 	 the branch nodes 1-4). A branch node can be at any place 
acid and protein sequences. In this format, a sequence is 	 where a leaf node locates, which results in further nesting of 
recorded with several fields of information including its 	 parentheses to any level. The comprehensive prokaryotic 
locus, definition, reference, and origin. Since only the abbre-  25 phylogenetic tree has 7,322 leaf nodes and 7,321 branch 
viated names of the organisms and the 16S rRNA sequences 	 nodes. Since the tree is far from being balanced (as the evo- 
in the sequence file are needed for the purpose of this project 	 lution of life itself is not balanced), some branches of the tree 
and all other information is redundant, it is necessary to 	 go very deep. 
extract the needed data from the sequence file and discard the 	 The Newick format of the tree file obtained from the RDP 
extra in order to increase the program efficiency. 	 30 website largely conforms to the Newick Standard described 
This data extraction functionality is fulfilled by subsystem 	 above with minor differences, such as the usage of comma 
I, the sequence file format conversion subsystem, which is 	 and single quote. See FIG. 10 for an example. The tree file 
composed of readseq and fasta2flat (FIG. 4). Readseq is a 	 contains taxonomic group identifiers and branch lengths. 
preinstalled program. It is a convenient and useful utility to 	 Much information is also recorded for every leaf node, which 
convert the format of a sequence file among Genbank, 35 includes the abbreviated organism name, the full name, and 
FASTA, and many other formats. FASTA format is also a 	 etc. When the program tree parser parses the tree file and 
common sequence format and usually used in sequence align- 	 builds the internal tree structure, only the abbreviated and full 
ment. In this format, a right angle bracket (">") prompts the 	 names of the organism are kept for each leaf node and all other 
sequence annotation on the same line, which is followed by 	 information is discarded. The abbreviated name is later com- 
the sequence itself starting on a new line. This project used 40 pared with every name in the set of matched organisms of 
readseq to change the 16S rRNA sequence file from Genbank 	 every oligonucleotide to determine if this leaf node is 
format to FASTA format. In this step only the names of the 	 matched by a particular oligonucleotide. The full name is 
organisms and the 16S rRNA sequences are retained while all 	 used purely for illustrative purposes whenever clear identifi- 
other information is discarded. 	 cation of an organism is necessary. Since this system does not 
Since the 16S rRNA sequence is long and expends several 45 use taxonomic group identifiers and evolutionary distances, 
lines in FASTA format, if is not convenient to use the 	 these data in the tree file were also ignored. 
sequences in this format. To further facilitate the manipula- 	 Due to the algorithms and methods used to construct the 
tion of the 16S rRNA sequences and the corresponding organ- 	 phylogenetic tree, almost all hylogenetic trees are bifurcat- 
ism names, the program fasta2flat takes the sequence file in 	 ing, that is, a branch node has exactly two child nodes: a left 
FASTA format as the input and rewrites the sequence data in 5o node and a right node. This feature of a phylogenetic tree 
a "flat' format, in which every line is a data entry starting with 	 makes a binary tree a natural and excellent choice of data 
the organism name, followed by a tab character ("\t') as the 	 structure to present it in a program. In some cases, the dis- 
separator followed by a string of letters (A, U, G, C), which is 	 tinction between the relative branching orders is very close 
the 16S rRNA sequence. 	 and three or more branches are shown as emerging at the same 
As shown in FIG. 4, Subsystem I converts the format of the 55 node. Such nearly bifurcating trees are not a problem for the 
sequence file. Subsystem II builds the binary prokaryotic 	 method as they are readily reduced to a bifurcating tree. The 
phylogenetic tree and the composite oligonucleotide hash. 	 tree file in Newick format is parsed in a stepwise and bottom- 
These internal data structures were used to calculate the func- 	 up manner. Program tree parser scans the tree file and add 
tion value at each branch tree node. 	 one leaf node a time to the nascent internal tree facilitated by 
Release 7 from RDP contains a total of 7,322 prokaryotic 6o a stack of references. FIG. 6 shows how a simple internal 
16S rRNA sequences. However, not all of these sequences 	 binary tree is built step by step (the reference stack is not 
can be used to generate the set of oligonucleotides (please 	 shown). 
refer to the section on program probes—hash—table—generator 	 FIG. 6 shows how the tree file in Newick format is parsed 
for explanation on how the set of oligonucleotides was gen- 	 in a stepwise and bottom-up manner. (a) A phylogenetic tree 
erated), because many of them are only partial sequences of 65 in Newick format. (b) The internal tree structure is built 
16S rRNAs (e.g. a sequence has only 300 nt instead of about 	 stepwise and from thebottom up. The filled circles denote leaf 
1,500 nt, the full length of 16S rRNA) and many contain 	 nodes and the hollow circles branch nodes. 
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Program tree parser builds the internal comprehensive 
prokaryotic phylogenetic tree using the tree file in Newick 
format as the blueprint and serializes it to an external binary 
file SSU_Prok.tree.bin forpossible later use. It then marks the 
leaf nodes in the internal tree structure "valid" or "invalid" 
according to the names of prokaryotes in file S SU_Prok.fasta. 
converted.valid, the output of program seq_classifier, and 
serializes the marked tree to file SSU_Prok.treeMarkedTotal. 
bin. This tree structure can be used later to calculate the 
function values, but the process is inefficient because nearly 
74% of the leaf node sequences are not of the very highest 
quality. The tree is large and the existence of invalid leaf 
nodes makes its size unjustifiable. Another difficulty is that 
some taxonomically different branch nodes may actually rep-
resent the same group of valid descendant leaf nodes. 
These potential difficulties were avoided by using a repre-
sentative tree based on only the highest quality sequences. 
Building such a representative tree requires a comprehensive 
analysis of the existing published tree of 7,322 sequences to 
determine which groupings and individual sequences, e.g. 
known pathogens, need to be included. This representative 
tree met these three qualifications: 
It only contains bacteria whose 16S rRNAs have been fully 
sequenced. 
At least one organism represents each major taxonomic 
grouping. 
The topology of this representative tree should conform to 
that of the comprehensive tree. In order to construct a 
representative tree, 929 bacteria are selected from 1,921 
prokaryotes whose 16S rRNA sequences are of the high-
est quality. The list of the leaf node numbers of these 929 
prokaryotes was kept in the text file selected leaf n-
ode–list. The resulting representative tree is far more 
comprehensive than the 98-sequence version provided 
RDP with its Release 7 dataset. 
In order to keep the topology of the representative tree in 
accordance with that of the comprehensive tree, after writing 
out the binary files SSU_Prok.tree.bin and SSU_Prok. 
treeMarkedTotal.Bin, program tree parser used the list of 
selected leaf nodes in file selected leaf node list as the ref-
erence to "trim away" (FIG. 7) invalid and valid-but-unse-
lected leaf nodes in the tree structure, resulting in a represen-
tative tree with 929 valid leaf nodes. This trimmed tree 
structure was serialized to the binary file SSU_Prok. 
treeMarkedTrimmed.bin, which was later used in the signa-
ture quality index value calculations. 
FIG. 5 illustrates that the trimming is stepwise and topol-
ogy conserving. Program select _seq takes three files SSU_ 
Prok.fasta.converted.valid, selected leaf node list, and 
SSU_Prok.tree.bin as the input and generates file SSU_ 
Prok.fasta.converted.valid selected as the output, which will 
be used to construct the composite oligonucleotide hash in the 
next step. Input file SSU_ Prok.fasta.converted.valid is the 
output of program seq_classifier. It contains all "valid" 16S 
rRNA sequences in a special "flat" format. File selected _le-
af node list keeps all leaf node numbers of the selected 
prokaryotes. SSU_Prok.tree.bin is the binary file from which 
the comprehensive prokaryotic phylogenetic tree is retrieved. 
The tree structure is used to index between the leaf node 
number and the abbreviated organism name in the corre-
sponding leaf node. The output file holds the 16S rRNA 
sequences of the selected organisms in the same format as 
S SU_Prok.fasta.converted.valid. 
Program probes–hash–table–generator is responsible for 
generating the composite hash, which records the needed 
information for each of all occurring oligonucleotides of a 
specific length from the 16S rRNA sequences dataset. The 
16 
program takes the probe length (x) as the command line 
argument and implicitly open sequence file SSU_Prok.fasta. 
converted.valid selected to get the abbreviated names of 
selected organisms and their corresponding 16S rRNA 
5 sequences. The hash for probes of length x is output as binary 
file hashForProbeLengthx.bin. 
Since only the oligonucleotides occurring in the 16S rRNA 
sequences are considered interesting, naturally all oligo-
nucleotides and their initial cognate information used in this 
10 
system are derived directly from the 16S rRNA sequences. If 
we consider the number of all possible oligonucleotides of a 
specific length, the computational saving by deriving oligo-
nucleotides directly from 16S rRNA sequences is substantial. 
15 Out of all possible 1,048,570 (4 10) decamers, 236,884 of 
them actually occur in the dataset of the 1,921 "valid" 16S 
rRNA sequences and 133,599 of them occur more than once. 
Only these 133,599 multi-occurring decamers (12.7% of all) 
are used in the next step to calculate the function values since 
20 we are only interested in identifying the phylogenetic neigh-
borhood/group of an unknown bacterium. By definition oli-
gonucleotides that are unique cannot be characteristic of a 
group. 
Program probes–hash–table–generator reads in the 
25 selected 16S rRNA sequences and for each sequence it 
excises oligonucleotides of the specified length from the 5' 
end, shifting one nucleotide at a time, to the 3' end (FIG. 8). 
Since an oligonucleotide can occur in 16S rRNAs from sev-
eral organisms and several times in one particular 16S rRNA, 
30 the occurring times (matchingTimes) of an oligonucleotide in 
the hash can only be equal to or greater than the number of the 
organisms (matchedOrg) whose 16S rRNAs it occurs in. FIG. 
8 illustrates how the composite hash of the oligonucleotides is 
built from the 16S rRNA sequences. 
35 	 At this point the system has completed the necessary pre- 
parative work, namely the sequence file format conversions 
and the data structure constructions. With those steps com-
plete, the system is now ready to calculate the function value 
at each branch tree node. Subsystem III, the function value 
40 calculation subsystem, consists of only one program—cal-
c_ node _value. It takes the probe length (x) as the command 
line argument and implicitly reads in the corresponding 
binary probe hash file hashForProbeLengthx.bin and the 
binary tree file SSU_Prok.treeMarkedTrimmed.bin. 
45 For each multi-occurring oligonucleotide from the hash 
reconstructed from the binary hash file, leaf nodes in the 
phylogenetic tree are marked if this sequence occurs in the 
16S rRNAs of the organisms at these leaf nodes. At each 
branch node the number of its descendent marked leaf nodes 
50 is counted by using the unusual backward pointers in the tree 
structure. The signature quality index values are calculated at 
all the branch nodes and then sorted in descending order. The 
top five highest values and their corresponding branch node 
numbers are kept as the value/key pairs in the treeNodeValues 
55 anonymous hash field of this probe in the composite hash. 
After the calculation is completed the result is output as a 
binary file hashForProbeLengthxCalc.bin, which is essen-
tially the same as the hashForProbeLengthx.bin except that 
the treeNodeValues for each multi-occurring oligonucleotide 
60 is populated with the calculation results. 
Subsystem IV, the result presentation subsystem, recon-
structs the composite probe hash and retrieves the calculation 
results from file hashForProbeLengthxCalc.bin. It is the open 
end of the system: the calculation result can be analyzed and 
65 presented in a variety of ways because any program, as long 
as it can reconstruct the composite hash from the binary file, 
can "plug into" the system via the subsystem IV and interpret 
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the calculation results in its own way. Currently this sub-
system consists of five programs (Table Q. 
Programs result reporter and result_ reporter
—, 
 as their 
names suggest, are a pair of similar result-presenting pro-
grams. They both take the length of probe (x) as the command 
line argument, reconstruct the composite hash filled with the 
calculation results from corresponding hashForProbe-
Lengthx Calc.bin, and give a list of signature sequences with 
information on their quality index, their identified branch 
nodes, and the descendent leaf nodes as the output files. The 
only difference between these two programs is that the former 
outputs the list of signature sequences sorted in descending 
order of the node numbers of the identified branch nodes 
while the list output by the later is sorted in descending order 
of the signature quality indexes. 
Programs group_node_lister and list —hit _branch—nodes 
present the result from the perspective of the taxonomic 
groups. group_node_lister lists all identified branch nodes 
along with their corresponding signature sequences of a par-
ticular length specified at the command line. list_hit —branch _ 
nodes takes a more ambitious approach. It gets all the calcu-
lation results of oligonucleotides from heptamer to 
undecamer from files hashForProbeLengthxCalc.bin 
(x7-11) and collects the number of times that a branch node 
is identified by characteristic oligonucleotides of a specific 
length at signature quality levels 0.6, 0.8, and 1.0 respectively. 
The analysis result of this program is the useful statistics 
which imply the relationships among the frequency with 
which a branch node is identified, the oligonucleotide length, 
and the signature quality. 
Program hybridize was used to test the usefulness of the 
characteristic oligonucleotides that the system has discovered 
so far. It takes a sequence file as the input in which every entry 
starts with a label followed by a tab character ("\t") as the 
separator followed by the actual 16S rRNA sequence. 
Although this program can use any reasonably good set of 
characteristic oligonucleotides as the hybridization probes, in 
this preliminary test nonameric signatures were used and they 
gave satisfactory results. When hybridize reads in a 16S 
rRNA sequence, it compares ("hybridizes") this sequence 
against all the characteristic oligonucleotides with a signature 
quality better than a specified threshold in the selected probe 
catalogue. When a probe is expected to bind to the 16S rRNA 
it is recorded by marking the corresponding branch node in 
the representative phylogenetic tree. The output of hybridize 
is one marked representative tree per each unknown 16S 
rRNA sequence plus a signature quality threshold (0. 6, 0. 8, or 
1.0). Some interesting and noteworthy features of the results 
will be discussed later. 
Valid 16S rRNA Sequences 
The 7,322 bacterial 16S rRNA sequences obtained from 
RDP release 7 have multifarious qualities. Some were fully 
determined in terms of both the length and every position of 
the sequence while others are either partially sequenced and/ 
or contain one or more undetermined positions. Any sequence 
that was either less than 1,400 nucleotides in length or has 
nucleotides other than AUGC (e.g. especially N standing for 
a position where the sequence could not be determined) was 
considered "invalid" by the system and was filtered away. 
Many of these sequences had very minor difficulties, i.e. 
marginally shorter than required or containing up to 3 uncer-
tain sequence assignments and could have been used without 
significant effect. However, since 1,921 16S rRNA sequences 
met the strongest criteria it was possible to maintain the very 
highest standard. Thus only the sequences deemed valid were 
retained to generate the sets of signature oligonucleotides. 
18 
Although the two conditions disqualifying problematic 
16S rRNA sequences greatly simplify-how the system deals 
with low-quality sequences, they are probably far too strict 
and as a result the current calculations likely did not make 
5 maximum use of all the sequence information in the dataset. 
Sequences a few nucleotides short of 1,400 nt or those that 
contain a small number of undetermined positions are cur-
rently discarded, even though their signature sequences 
remain mostly intact. To mitigate this problem, the quality 
io demands can be moderately relaxed, i.e. by lowering the 
length requirement and only discarding the oligonucleotides 
containing undetermined positions instead of the whole 16S 
rRNA sequence. However, if a representative phylogenetic 
tree is used instead of a comprehensive one (as in this system), 
15 the effect of losing sequence data should be mild since only a 
subset of 16S rRNA sequences are used anyway. If a branch 
of the comprehensive phylogenetic tree is absent from the 
representative tree due to lack of valid 16S rRNA sequences 
in that cluster, either the quality demands can be decreased as 
20 described above or sequences from two very closely related 
organisms can be fused to ensure that this particular branch 
will be included. Also, it should be appreciated that in some 
cases, the distinction between the relative branching orders 
may be very close in some areas of the tree. When this occurs 
25 it is not uncommon to show three or more branches emerging 
from the same node. Such nearly bifurcating trees are not a 
problem for the method as they are readily reduced to a 
bifurcating tree. 
Oligonucleotides in 16S rRNA Sequence Dataset 
30 The number of all possible oligonucliotides of a specific 
length evidently depends on both the length and how many 
different nucleotides are legitimate at each position. Given 
that there are four different nucleotides (A, U, G, C in RNA 
and A, T, G, C in DNA), if the length of the oligonucleotide is 
35 n, the number of all possible length-n oligonucleotides is 4". 
When length n is large, the oligonucleotides occurring in the 
16S rRNA sequence dataset are only a non-random fraction 
of all possible oligonucleotides and there is no simple for-
mula to calculate this number. Table D summarizes these 
4o numbers for oligonucleotides under consideration in this sys-
tem from hexamer to undecamer. FIG. 9 plots these data and 
gives a direct visual perception of the trends. 
FIG. 9 shows that the number of oligonucleotides and the 
length are related. (a) The number of all possible oligonucle- 
45 otides increases exponentially with the length. The curve is 
described by function f(x)=4". (b) The numbers of the total 
and multi-occurring oligonucleotides in the 16S rRNA 
sequence dataset also increase with the length. The increases 
are slower than that in (a) due to the sequence context con- 
50 straint from 16S rRNA. 
Signature Oligonucleotides in 16S rRNA Sequence 
Dataset 
At a branch node in the phylogenetic tree, if an oligonucle-
otide gives a quality index value greater than a preset value, 
55 this oligonucleotide is said to be a signature at that branch 
node since it can identify that node better than other oligo-
nucleotides which have a lower value of the quality index. In 
the current system, 0.6 is the cutoff value, i.e. only oligomers 
with function value over 0.6 at a branch node will be pre- 
60 sented in the results. 
Of course, several signatures may identify a branch node 
and an oligonucleotide may also be a signature simulta-
neously at several branch nodes. Clearly, the higher the qual-
ity index value of a signature at a branch node is, the better it 
65 can identify that node. A signature with a function value of 0.8 
is better than one with a function value of 0.6 at the same 
branch node and a signature with function value 1.0 is perfect 
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for that node, which, according to the definition of the signa- 	 the representative tree is shown in FIG. 12. The numbers of 
ture quality function, Q, means that all 16S rRNAs having 	 nonameric, undecameric and 15-mer signature sequences at 
this signature sequence are in the same phylogenetic group 	 each of the 11 branch tree nodes in this 12 organism sub-tree 
defined by that branch node and thus no 16S rRNAs with the 	 in different ranges of quality levels are summarized in Table 
same signature are outside that group. 	 5 F. Tree node 5547 does not have any signatures at the Qs 1.0 
Signatures of different lengths are distributed in the phy- 	 level whereas its parent branch, node 5549, has 14 perfect 
logenetic tree differently. The general observation is that long 	 nonameric/undecameric/15-mer signatures. Several of these 
and short signatures have polar distributions in the tree: the 	 are the same sequences, which serve as signatures for node 
long signatures tend to identify the branch nodes near the tree 	 5547 at values of Qs at the 0.8 level. This result draws atten- 
leaves while the short ones are more likely to pick out those 10 tion to the fact that many individual oligonucleotides are 
near the tree root. This trend is evident when the results of 	 signatures of several branch nodes at differing levels of Q s . 
pentameric and undecameric signatures are compared. The 	 This reflects the child/parentrelationship between nodes. The 
result shows that 35 out of 35 (100%) perfect (Q 9 1.0) pen- 	 signatures identifying the taxonomical group represented by 
tameric signatures identify the root while 11,958 out of 	 the local root node 5577 of the representative tree illustrate 
18,746 (64%) perfect undecameric signatures identify the 15 another common feature. Of the 17 perfect signatures for 
two-leaves as two children branches. 	 node 5577, five are nonameric, six undecameric and six are 
Short signatures, e.g. pentamers and hexamers examined 
	
15-mers. However, every one of these five nonameric signa- 
by the system, are generally too unspecific to identify any 	 tures appears as a part of one of the six undecameric signa- 
interesting small groups in the phylogenetic tree with Q. 	 tures. This inclusion of shorter signature sequences is a part of 
They tend to identify the whole bacterial tree instead. How-  20 a longer one is frequently seen regardless of the signature 
ever, if a smaller nucleic acid such as 5S rRNA is used then 	 length, the signature quality level and the position of interest 
sequences of this length might be significant. On the other 	 in the phylogenetic tree. 
hand, long signatures, e.g. undecameric and longer oligo- 
nucleotides, are increasingly specific and therefore more use- 	 Example 2 
ful to identify individual organisms and two-leaves-as-two-  25 
children groups. Signatures with a length between seven and 
	
In Silico Hybridization 
eleven should have a more balanced distribution in the phy- 
logenetic tree. 	 Once the characteristic oligonucleotides (signature 
2,533 nonameric signatures can identify phylogenetic 	 sequences) from 16S rRNA sequence dataset are identified, 
groups with three or more (up to 23) members perfectly. 30 they can be used to implement in silico hybridization (This is 
On >0.8 and >0.6 quality levels there are 5,580 and 15,340 	 not carried out in the laboratory. Instead, it is performed 
nonameric signatures respectively. At this length, the signa- 	 virtually by a computer program, thus, in silico). This proce- 
ture sequences cover/identify —80% of the phylogenetic 	 dure can be either executed as a standard experimental routine 
groups in the representative tree. The user can refer to Table E 	 or in this case as a quick test of the validity of the signatures, 
for a quick comparison. 	 35 which have been identified. 
In Table E a "gap' between the numbers of signatures 	 Since these characteristic oligonucleotides were derived 
shorter than octamers and those longer than heptamers is 	 from the selected valid 16S rRNA sequences using the cor- 
evident. On every level of signature qualities examined, 	 responding representative tree, several valid 16S rRNAs that 
namely where QS is equal to 1.0, 0.8, or 0.6, there is a sharp 	 were not selected to make the representative tree were chosen 
unexpected increase in the number of signatures and tree 4o as 16S rRNAs from "unidentified" bacteria. Program hybrid- 
coverage from heptamers to octamers. 	 ize was used to perform in silico hybridization between the 
Table E provides a comparison among signatures of vari- 	 unknown 16S rRNAs and the characteristic oligonucleotides. 
ous lengths ranging from pentamers to undecamers and also 	 The unknowns were thus placed in their predicted phyloge- 
15-mers. Only signature sequences that can identify phylo- 	 netic neighborhoods in the representative tree. Because the 
genetic groups with three or more members are counted in 45 comprehensive phylogenetic tree is available, thus the valid- 
constructing this table. A computer program is used to calcu- 	 ity of the predictions could be quickly and definitively 
late the coverage. Any branch nodes other than those that have 	 checked. 
two leaf nodes as their two child nodes in the representative 	 This in silico hybridization experiment was set up with 
tree are regarded as phylogenetic groups (635 in total). The 	 these the following parameters: Probes length: 9 (nonameric) 
signature quality QS is greater than 0.6. 	 5o and 11 (undecameric) quality level: 0.6, 0.8, and 1.0 
16S rRNAs control: Escherichia coli (E. coli) 
ILLUSTRATIVE EXAMPLES 	 tests with the following valid sequences: 
Methanobacterium form icicum (Mb.fonnici) 
Example 1 
	
Tetragenocuccus halophiles (Tgc.halop2) 
55 	 Orientia tsutsugamushi (Ort.tsuts6) 
A Local Region of the Tree & its Associated 	 test done with following invalid sequence: 
Signatures 	 the isolate M2 of the symbiont of methanogen (sym.M2) 
The four agents in this example are chosen in a random way 
The purpose of this example is to better illustrate the rela- 	 with maximum distribution in the comprehensive tree. 
tionship between the signature sequences found and the 60 	 The results of this example are very promising. All five 
nodes of the tree used in a more detailed level. Table F, lists 	 bacteria, namely one control and four test organisms, are 
only the results with reference to a local region of the com- 	 placed in the correct phylogenetic neighborhoods. The cor- 
prehensive tree. Before trimming this region contained 16S 	 rectness of the placements is confirmed by the positions of 
rRNAs representing 38 organisms. A total of 23 of these 	 those five organisms in the comprehensive tree. 
sequences were of the very highest quality but many of them 65 	 The control, E. coli at leaf node 7270 under branch node 
were very similar so a total of 12 sequences were selected for 	 7224 in the comprehensive tree, is unambiguously placed 
final inclusion in the representative tree. This local region of 	 under branch node 7259 with E. coli (itself), E.coli7, and 
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This example by no means limits the invention to charac-
teristic oligonucleotides in 16S rRNA sequence dataset. On 
the contrary, it encompasses many variations and specific 
improvements including, but not limited to the following: 
5 1. Use of new data available at RDP (both the newly 
released 16S rRNA sequences of release 8.1 and an updated 
prokaryotic phylogenetic trees). 
2. Improvements to the representative tree, e.g. to provide 
that every cluster of prokaryotes in the comprehensive tree is 
10 
represented by at least one bacterium in this tree. Where 
possible, merging of pairs of two closely related but not full 
length sequences to obtain a full length representation of that 
tree region may be possible. It also may be useful to better 
weight the number of entries from various clusters. 
3. Use of different but sensible functions to calculate the 
15 signature quality index. Since the quality index is the most 
important tool for evaluating the signature potential of oligo-
nucleotides in this system, changing the function can have a 
substantial impact on the specific result. 
4. Assembling and use of a comprehensive set of charac- 
20 teristic oligonucleotides, by which the majority of the groups 
and all of the important groups in the representative tree can 
be identified. The oligonucleotides in this set are likely to 
have various lengths. 
5. Applying mathematical and programming techniques to 
25 facilitate the final interpretation of hybridization results. 
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E. colirnG3 as three leaf nodes when probes at Qs 1.0 are used 
The best example of the four cases is probably Ort.tsuts6, 
which resides at leaf node 5404 under branch node 5383 in the 
comprehensive tree. This prokaryote was uniquely placed 
under branch node 5391 with Ort.tsuts9 at the only direct leaf 
node 5411 of this branch node. Another particularly notewor-
thy and interesting case is the identification of sym.M2. The 
sequence of the 16S rRNA from this organism has only 359 
nucleotides with one undetermined position. The correct 
placement of this prokaryote in the representative tree was 
possible because some signature sequences in its poorly 
sequenced 16S rRNA apparently remained intact and identi-
fiable. 
Although the prokaryotic organisms could be placed in 
correct clusters, there were positive errors, i.e. some groups, 
which are not in the correct phylogenetic neighborhoods, 
were positively identified. This kind of error occurs because 
many of the signature sequences used have a value of Q S of 
less than 1. The number of these false positive errors 
decreased as the probe quality Qs increased from 0.6 to 1.0, 
but as to a specific organism and a specific probe quality level 
there was no dramatic difference in the error rate between 
using nonameric and undecameric probes. Despite this 
imperfection, one point should be stressed: even though the 
false positives occur, the correct phylogenetic neighborhoods 
are among the groups identified in all cases. Moreover, the 
correct neighborhood is readily identified by the presence of 
multiple hits whereas the noise placements are frequently 
loners. This is a very important aspect of the method, which 
stems directly from the parent/child relationship between 
nodes in a bifurcating tree. Thus, false positives are not a 
serious impediment to success. False negatives are also not a 
problem because of the redundancy of signature sequences 
that occur at many nodes. 
This example shows that when a small set of 16S rRNA 
sequences are analyzed, at least some signature sequences 
exist that are representative of the phylogenetic groups that 
can be identified by tree constructions based on the complete 
16S rRNA. sequences. The consequence of having thousands 
of such sequences in the dataset was not known in the prior 
art. Possibly noise would build Up to the extent that useful 
signatures would be obscured. Even if such sequences con-
tinued to exist in the larger data set it was not clear that their 
numbers would be useful nor was it clear that they could be, 
readily identified. 
The results establish beyond any doubt that characteristic 
oligonucleotides in the bacterial 16S rRNA sequence dataset 
do in fact exist in huge numbers. Over 15,000 nonamers alone 
were identified, with in many cases multiple coverage of the 
various phylogenetic groupings in the 929 organism repre-
sentative tree. 
It is invaluable to identify these signature sequences 
because a group of evolutionarily related bacteria can be 
distinguished from other groups by a set of characteristic 
oligonucleotides specific to that group. The existence of these 
signatures is a direct demonstration of an innate characteristic 
of the evolution of bacterial 16S rRNAs that can be utilized to 
identify an unknown prokaryotic agent by elucidating its 
immediate phylogenetic neighborhood. These characteristic 
oligonucleotides can be used as the basis for developing 
hybridization probes that can be used in order design valuable 
oligonucleotide microarrays. Herein the utility of the signa-
ture sequences was tested by in silica hybridizations using as 
unknowns sequences that had not been included in the origi-
nal representative tree. These studies demonstrated that the 65 
characteristic oligonucleotides in the unknown organisms 
readily provided their correct placement in the tree. 
Example 3 
Soil Samples 
Example 5 
Air Sample 
Nucleic acids isolated from an air filtrate are aliquoted into 
50 wells of a fluorescence microtiter plate, each well contain- 
30 	 16S rRNA is purified from an unknown organism isolated 
from soil and amplified by RT-PCR using primers directed to 
conserved regions and flanking a variable region of the mol-
ecule. The PCR products are subjected to digestion by a 
restriction endonuclease, flourescently labeled with cy5, and 
35 then hybridized to an array of all possible 8-mer peptide 
nucleic acids. After washing, the pattern of hybridization is 
observed by confocal laser fluorescence scanning, and inter-
preted in terms of the known signature sequences for bacteria 
and the organism is assigned to the genus Nocardia. 
40 
Example 4 
Soil Samples 
45 	 16S rRNA is purified from an unknown organism isolated 
from soil and amplified by RT-PCR using primers directed to 
conserved regions and flanking a variable region of the mol-
ecule. The PCR products are subjected to digestion by a 
restriction endonuclease, fluorescently labeled with cy5, and 
50 then hybridized to an array of 5,000 DNA probes designed to 
recognize the 16S rRNA sequences of particular species. 
After washing, the pattern of hybridization is observed by 
confocal laser fluorescence scanning, and no significant 
hybridization is found. The same labeled nucleic acids are 
55 then hybridized to an array of 4,000 probes to bacterial sig-
nature sequences identified by the methods of this invention. 
After washing, the pattern of hybridization is observed by 
confocal laser fluorescence scanning, and interpreted in terms 
of the known signature sequences for bacteria and the organ- 
60 ism is assigned to the genus Bacillus. 
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ing a 5'-FITC, 3'-quencher molecular beacon hairpin probe 
specific for a selected signature sequence. After heating to 
95C for 5 minutes, the plate is allowed to cool slowly to room 
temperature, and fluorescence is read. The pattern of fluores-
cence is compatible with the presence of a strain of Staphy-
lococcus. That is closely related to a known pathogenic strain. 
Example 6 
Mutated Protease 
Nucleic acids of a virus are isolated and amplified from a 
blood sample and signature sequences are scored using the 
Qiagen Genomics Masscode sequence detection technology. 
The presence of particular signature sequences permits iden-
tification of a strain bearing a mutation of a previously-known 
protease, which confers on it resistance to particular thera-
peutic drugs. 
Example 7 
Meat Sample 
24 
using the Qiagen Genomics Masscode sequence detection 
technology. Eight signature enzyme activities are also 
assayed for and two are found, and 24 proteins whose pres-
ence can serve as signatures are assayed for by ELISA, and 
5 two are detected. The combined presence of particular signa-
ture sequences, activities, and proteins permits identification 
of a particular viral strain. 
Example 11 
10 
Bioterrorism 
Air filtrate from a government building is collected and 
nucleic acids isolated. rRNA is enriched using DNAse and 
15 RNA fragmented by heating. Probes specific to several 
known bioterrorism agents give negative results. Molecular 
beacon-based scoring of signature sequences reveals thepres-
ence of unexpectedly high concentrations of bacteria with 
genetic affinity to the genus Bacillus. Further investigation 
20 reveals an engineered variant strain of B. anthracis, and the 
buildings evacuated. It is noted that the prior art known to 
Applicants would fail to identify this engineered strain. 
Nucleic acids are isolated from a meat sample claimed to 
be goose liver and signature sequences are scored using the 25 
Third Wave Technologies Invader directed-cleavage assay. 
The presence of a particular signature sequence indicates the 
presence of turkey meat as an adulterant. 
Example 8 
	 30 
Blood Sample 
Blood taken from the bed of a pickup truck owned by a 
suspected poacher is analyzed for signature sequences of 35 
mammalian mitochondrial DNA using individual hybridiza-
tion assays detected by chemiluminescence produced by an 
alkaline-phosphatase-conjugated RNA/DNA-specific anti-
body. The results suggest the blood comes from an animal of 
the genus Euarcturos, and the suspect is arrested on suspicion 40 
of poaching the American black bear. 
Example 9 
Air Sample 	 45 
Nucleic acids isolated from an air filtrate are aliquoted into 
50 wells of a fluorescence microtiter plate, eachwell contain-
ing a 5'-FITC, 3'-quencher molecular beacon hairpin probe 
specific for a selected 18S rRNA signature sequence. After 50 
heating to 95C for 5 minutes, the plate is allowed to cool 
slowly to room temperature, and fluorescence is read. The 
pattern of fluorescence is compatible with the presence of 
both a mold belonging to the genus Stachybotrys and a fungus 
belonging to the genus Aspergillus. Two DNA oligonucle-  55 
otides (one 5' biotinylated) corresponding to two signature 
sequences found in the sample are used in a PCR reaction to 
amplify a segment (of predicted length 46 nucleotides, based 
on the positions of the signature sequences in the 16S rRNA 
sequence) of rDNA. The biotinylated product is immobilized 60 
in single-stranded form and used as a probe for high-affinity, 
high-specificity detection of a novel species of Stachybotrys. 
Example 10 
65 
Nucleic acids of a virus are isolated and amplified from a 
blood sample and signature nucleic acid sequences are scored 
MODIFICATIONS 
Specific compositions, methods, or embodiments dis-
cussed are intended to be only illustrative of the invention 
disclosed by this specification. Variations on these composi-
tions, methods, or embodiments are readily apparent to a 
person of skill in the art based upon the teachings of this 
specification and are therefore intended to be included as part 
of the inventions disclosed herein. Particularly preferred spe-
cies and ranges of parameters are partially summarized by 
Table G. 
The nucleic acid sequences included in the database can be 
any ribosomal RNA, or a fragment thereof, or DNA encoding 
ribosomal RNA or a fragment thereof, or the DNA spacer 
region between rRNA genes; or either the genomic DNA or 
RNA of viruses, or artificial RNAs, or any functional RNA 
molecule such as RNAse P RNA that is found in a useful 
variety of organisms. The molecule actually detected may be 
one that has a sequence related to the molecule represented in 
the database, for example PCR, NASBA or RT-PCR products, 
derived from rRNA or rDNA. 
Once identified, signature sequences will preferably be 
used in the design of hybridization probes. In this regard, the 
set of unique sequences of various lengths are perfect signa-
tures for the specific organism that they are found in and 
therefore are obvious candidates for use in the design of 
specific hybridization probes for that organism. If a node is 
associated with multiple signature sequences, as many are in 
the case of 16S rRNA, it will be preferable to utilize the one 
or more with the most favorable hybridization properties. 
Depending on the experimental setting, the actual probe can 
preferably incorporate portion or all of either a particular 
signature sequence or its complement. There are also obvious 
mathematical relationships between the signature sequences 
of different lengths. Thus, for example, a 16 base signature 
sequence that is perfect for node N will necessary show up in 
the 8 mer signature set as 9 different unique signature 
sequences for node N (i.e. representing positions 1-8, 2-9,3-
10,4-11,5-12,6-13,7-14,8-15,9-16 in the 16-mer). Therefore, 
one will be able to combine signature sequences in some 
cases to serve as a starting point in the design of longer 
probes. Many signature sequences that do not share the type 
of relationship described above may still be sufficiently near 
each other in the primary sequence that it will be possible to 
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26 
combine them to design a longer probe. This can be accom- 	 comprise matrix-assisted laser desorption ionization 
plished, for example, by including a "wildcard" hybridiza- 	 (MALDI) or electrospray or TOE or resonance methods can 
tion base such as inosine at certain positions. More generally, 	 be used to determine mass within 10%, more preferably 2% 
a variety of non-standard bases can be used to modify the 	 and most preferably 1% for each sequence. Likewise appli- 
hybridization properties of a probe based on a signature 5 cations exist where signature sequences can be used in the 
sequence. Also the properties of a signature sequence can be 	 design of PCR primers to amplify larger regions of DNA or 
modified to adapt them for use with organisms represented by 	 RNA. For example, a completely unknown organism is 
another node. Individual monomers in probes or other 	 detected by the method of the invention and best assigned to 
sequences derived from signature sequences can be modified 	 a large early branching group. The probes that detected this 
to facilitate hybridization, or detection. This includes but is io affiliation could then be used as amplification primers to 
not restricted to incorporation of fluorophores, chemically- 	 readily obtain a large region for full sequencing or as a longer 
labile moieties, isotopes, or halogen atoms. Modifications 	 probe. 
can be incorporated in the course of replication by DNA 
	
Although the invention is preferred for use with functional 
polymerase or RNA polymerase. Labels can be incorporated 	 nucleic acids it can also be used with DNA sequences such as 
in the course of PCR, RT-PCR or NASBA. 	 15 genes that encode protein. In this case, a database of genes for 
Detection can employ a variety of known methods, both 	 the equivalent protein from a sufficient number and variety of 
those based on sequence-specific hybridization and other- 	 organ sms or viruses would be needed. The tree used might be 
wise. Hybridization can be to RNA or DNA, but also to 	 deduced from the genes themselves but in order to avoid 
peptide nucleic acids, locked nucleic acids, branched nucleic 	 possible complications of lateral gene transfer a is preferable 
acids, cyclic probes, backbone-modified nucleic acids, and 20 to use a tree based on 16S rRNA sequence data. 
base-modified nucleic acids. Array formats (on single or mul- 	 When the invention is used with viruses, it is necessary to 
tiple, e.g., bead supports) will often be valuable. Hybridiza- 	 appreciate that all viruses do not share a single common 
tion can lead to the capture of a labeled nucleic acid on a solid 	 ancestor. There are many distinct groups of viruses, e.g. the 
support such as a bead, membrane, or array. Labels can be 	 Flaviviridae, which is a large family of single stranded posi- 
isotopes, chemically-detectable tags, liquid crystals, cleav-  25 tive sense RNA viruses that includes the causative agents of 
able chemical tags, fluors, quantum dots, or enzymes such as 	 yellow fever, St. Louis encephalitis, Japanese encephalitis, 
alkaline phosphatase, ribozymes, or peroxidase. Enzymes 	 hepatitis C, and Dengue fever. The genomes typically in the 
can produce heat, color, fluorescence, chemiluminescence, 	 size range 9,500-12,500 nucleotides some with DNA 
precipitates, bioluminescence, changes in liquid crystalline 	 genomes and some with RNA genomes. Several common 
order, or changes in nucleic acid structure. Hybridization can 30 genes exist and hence meaningful phylogenetic trees can be 
also lead to production of signals by self-quenching probes 	 developed which span the entire group. Thus, it is possible to 
such as molecular beacons, or by ribozyme activation, FRET 	 generate signature sequences that are specific for Dengue 
pairs, or changes in plasmon resonance or similar interfacial 	 serotype type II or Dengue in general, etc. The methods of the 
optical phenomena, in mechanical resonant frequency, in 	 invention can be used for any virus group as long as a mean- 
redox activity or electrical conductivity, in electrophoretic or 35 ingful tree can be produced. However, the sample preparation 
chromatographic mobility, in affinity for chelated metals, 	 may require more steps. The different types of nucleic acid 
minerals, or antibodies or proteins, or in particle or molecular 	 involved (single strand positive sense RNA, double stranded 
mobility. Robotic methods of preparation and microtiter 	 DNA etc.) may limit the number of viruses groups that can be 
plates can be employed with the invention to further automate 	 detected in one experiment. 
multiple assays. 	 40 	 Features preferred with the invention in certain cases com- 
The method of the invention is especially useful when the 	 prise: the nucleic acid is DNA that encodes ribosomal RNA or 
hybridization probes consist of every possible sequence of 	 a fragment or a complementary sequence of the foregoing; the 
one length. For example, there are 65,536 unique 65,536 	 nucleic acid is RNA complementary to one of the strands of 
octamers. The signature characteristics of every one of these 	 the DNA that is in the spacer region between ribosomal RNA 
octamers are obtained by the method of the invention for any 45 genes or a fragment of the foregoing; the nucleic acid is DNA 
nucleic acid of interest. When the nucleic acid being used is 	 isolated from the spacer region between ribosomal RNA 
16S rRNA or 16S rDNA the same array can be used for any 	 genes or a fragment of the foregoing; the nucleic acid is any 
bacterial identification. If multiple organisms are present this 	 non mRNA produced by the cell or a fragment of the forego- 
will apparent as there will be conflicting signatures. Only the 	 ing; the nucleic acid is any mRNA produced by the cell or a 
sample preparation procedure would differ. The same array 50 fragment of the foregoing; the nucleic acid is genomic DNA 
can also be used with any other nucleic acid. Hence by chang- 	 or a fragment of the foregoing; the signature quality index Q s 
ing the nucleic acid to the positive strand genomic RNA of the 	 includes terms that weight against false positives and false 
flavivirus family, the experimental results would be useful in 	 negatives; the tree contains some multiple branchings but is 
identifying the closest known genetic relatives of the test 	 substantially bifurcating; the genetic affinity of bacteria of 
virus in this virus group. It is an important aspect of the 55 eukaryotic organisms is determined; the genetic affinity of 
invention that it is not necessary that all the oligomers in the 	 more than one bacterial or eukaryotic organism can be deter- 
array need work properly. There is frequently a high redun- 	 mined in a single experiment; wherein the nucleic acid is 
dancy of signature sequences associated with a particular 	 DNA that encodes ribosomal RNA or a fragment or a comple- 
node so that if several fail the node will still give a signal if it 	 mentary sequence of the foregoing; the nucleic acid is RNA 
is represented in the sample. 	 60 complementary to one of the strands of the DNA that is in the 
Although signature sequences will be preferably be used in 	 sparer region between ribosomal RNA genes or a fragment of 
conjunction with hybridization methods of various types, it 	 the foregoing; the nucleic acid is DNA isolated from the 
should be noted that these sequences also have unique physi- 	 spacer region between ribosomal RNA genes or a fragment of 
cal properties. Therefore, if a plurality of signature sequences 	 the foregoing; where the nucleic acid is any non mRNA 
are generated by experimental means, e.g. by digestion with 65 produced by the cell or a fragment of the foregoing. 
ribonuclease TI or a restriction endonuclease, these physical 
	
Other preferred features comprise: the nucleic acid is any 
properties can be measured. Mass spectrometry which can 	 mRNA produced by the cell or a fragment of the foregoing; 
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the nucleic acid is genomic DNA or a fragment of the fore-
going; the genetic affinity of more than one virus can be 
determined in a single experiment; the nucleic acid is a ribo-
somal RNA or or a fragment or a complementary sequence of 
the foregoing; the nucleic acid is DNA that encodes riboso- s 
mal RNA or a fragment or a complementary sequence of the 
foregoing the nucleic acid is RNA complementary to one of 
the strands of the DNA that is in the spacer region between 
ribosomal RNA genes or a fragment of the foregoing; the 
nucleic acid is any non mRNA produced by the cell or a io 
fragment of the foregoing the nucleic acid is any mRNA 
produced by the cell or a fragment of the foregoing; the 
nucleic acid is genomic DNA or a fragment of the foregoing; 
the signature probes are of not all of the same length; the 
signature probes represent signature genes; choosing a tree of 15 
relationships that can be reasonably expected to signify 
genetic relationship was previously published or otherwise 
generated by a third party, the hybridization probes are 
complementary or the same sense as the signature sequences; 
a plurality of signature sequences is combined into one or 
28 
more larger hybridization probes; a hybridization probe 
incorporates a portion of the information in a signature 
sequence; the signature probes are comprised of a nucleic 
acid analog comprising PNA, T-0-methyl DNA or analog 
thereof; the presence or absence of a signature sequence in a 
test sample is determined by physical characterization the 
signature sequences are identified by the method of claim 1. 
physical characterization is done with mass spectrometry; the 
nucleic acid molecule is a DNA molecule; the DNA molecule 
is a cDNA molecule. 
The invention may also be applicable in unexpected situa-
tions. For example, there are currently a large number of 
genomes being completely sequenced. When one assembles 
phylogenetically meaningful clusters of whole genome 
sequences there are certain genes that are highly characteris-
tic of particular clusters of organisms. These signature genes 
can be used in the invention to identify unknown organisms, 
preferably by detecting the presence of activities or gene 
products associated with the signature genes rather than a 
nucleic acid assay. 
SEQUENCE LISTING 
<160> NUMBER OF SEQ ID NOS: 54 
<210> SEQ ID NO 1 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 1 
aaaaaaacag ucuca 	 15 
<210> SEQ ID NO 2 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 2 
aaaaaaacag ucuca 	 15 
<210> SEQ ID NO 3 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 3 
aaaaaaacag ucuca 	 15 
<210> SEQ ID NO 4 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 4 
aaaaaaacag ucuca 	 15 
<210> SEQ ID NO 5 
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30 
-continued 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 5 
aaaaaaacag ucuca 	 15 
<210> SEQ ID NO 6 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 6 
aaaaaaagac gguac 	 15 
<210> SEQ ID NO 7 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 7 
aaaaaaagac gguac 	 15 
<210> SEQ ID NO 8 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 8 
aaaaaaagac gguac 	 15 
<210> SEQ ID NO 9 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 9 
aaaaaaagac gguac 	 15 
<210> SEQ ID NO 10 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 10 
aaaaaaagac gguac 	 15 
<210> SEQ ID NO 11 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 11 
US 8,214,153 B1 
31 
	
32 
-continued 
aaaaaaauga cggua 
<210> SEQ ID NO 12 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
is 
<400> SEQUENCE: 12 
aaaaaaauga cggua 	 15 
<210> SEQ ID NO 13 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 13 
aaaaaaauga cggua 	 15 
<210> SEQ ID NO 14 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 14 
aaaaaaauga cggua 	 15 
<210> SEQ ID NO 15 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 15 
aaaaaaauga cggua 	 15 
<210> SEQ ID NO 16 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 16 
aaaaaacagu cucag 	 15 
<210> SEQ ID NO 17 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 17 
aaaaaacagu cucag 	 15 
<210> SEQ ID NO 18 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
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-continued 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 18 
aaaaaacagu cucag 	 15 
<210> SEQ ID NO 19 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 19 
aaaaaacagu cucag 	 15 
<210> SEQ ID NO 20 
<211> LENGTH: 15 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: sequence composed of several organisms 
<400> SEQUENCE: 20 
aaaaaacagu cucag 	 15 
<210> SEQ ID NO 21 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: M.mycoides 
<220> FEATURE: 
<223> OTHER INFORMATION: Organism specific sequences 
<400> SEQUENCE: 21 
aaaaaaacca gu 	 12 
<210> SEQ ID NO 22 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 22 
aaaaaaacgu gc 	 12 
<210> SEQ ID NO 23 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 23 
aaaaaaaguu uc 	 12 
<210> SEQ ID NO 24 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 24 
aaaaaaauaa as 	 12 
<210> SEQ ID NO 25 
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36 
-continued 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 25 
aaaaaaauga ag 	 12 
<210> SEQ ID NO 26 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 26 
aaaaaaauua gg 	 12 
<210> SEQ ID NO 27 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 27 
aaaaaaauuu au 	 12 
<210> SEQ ID NO 28 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 28 
aaaaaacacg uc 	 12 
<210> SEQ ID NO 29 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 29 
aaaaaaccaa cc 	 12 
<210> SEQ ID NO 30 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 30 
aaaaaaccaa uc 	 12 
<210> SEQ ID NO 31 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: B.pallidus 
<220> FEATURE: 
<223> OTHER INFORMATION: Organism specific sequences 
<400> SEQUENCE: 31 
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38 
-continued 
aaaaaaccac uc 
<210> SEQ ID NO 32 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
12 
<400> SEQUENCE: 32 
aaaaaacccu uc 	 12 
<210> SEQ ID NO 33 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 33 
aaaaaaccgg cc 	 12 
<210> SEQ ID NO 34 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 34 
aaaaaaccgg uc 	 12 
<210> SEQ ID NO 35 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 35 
aaaaaacgug cc 	 12 
<210> SEQ ID NO 36 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 36 
aaaaaacuaa ag 	 12 
<210> SEQ ID NO 37 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 37 
aaaaaacucu gc 	 12 
<210> SEQ ID NO 38 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
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-continued 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 38 
aaaaaacuga cg 	 12 
<210> SEQ ID NO 39 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 39 
aaaaaagaag ca 	 12 
<210> SEQ ID NO 40 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 40 
aaaaaagagu gg 	 12 
<210> SEQ ID NO 41 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 41 
aaaaaagccc ac 	 12 
<210> SEQ ID NO 42 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 42 
aaaaaagccg uc 	 12 
<210> SEQ ID NO 43 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 43 
aaaaaagccu ua 	 12 
<210> SEQ ID NO 44 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 44 
aaaaaagggg ga 	 12 
<210> SEQ ID NO 45 
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42 
-continued 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 45 
aaaaaaguug uc 	 12 
<210> SEQ ID NO 46 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 46 
aaaaaaguuu cg 	 12 
<210> SEQ ID NO 47 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 47 
aaaaaauaaa ac 	 12 
<210> SEQ ID NO 48 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 48 
aaaaaauacu cc 	 12 
<210> SEQ ID NO 49 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 49 
aaaaaauaga gu 	 12 
<210> SEQ ID NO 50 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 50 
aaaaaauaug uc 	 12 
<210> SEQ ID NO 51 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 51 
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44 
-continued 
aaaaaaucaa as 	 12 
<210> SEQ ID NO 52 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 52 
aaaaaaucaa au 	 12 
<210> SEQ ID NO 53 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 53 
aaaaaaucaa uc 	 12 
<210> SEQ ID NO 54 
<211> LENGTH: 12 
<212> TYPE: RNA 
<213> ORGANISM: Unknown 
<220> FEATURE: 
<223> OTHER INFORMATION: source could not be determined 
<400> SEQUENCE: 54 
aaaaaaucca uc 	 12 
What is claimed is: 	 35 	 E. Deriving a plurality of signature probes from the signa- 
1. A method for determining the genetic affinity of organ- 	 ture database of characteristic signature sequences that 
isms or viruses in a test sample containing a target nucleic 	 will be complementary to a portion of the target nucleic 
acid, comprising in combination the steps of: 	 acid sequence of the organism or virus if the signature 
A. Obtaining or creating a nucleic acid sequence database 	 sequence is present; 
of a plurality of sequences, each nucleic acid sequence 40 	 F. Hybridizing aplurality of the signature probes represent- 
being from the same corresponding nucleic acid from all 
	
ing multiple nodes in the bifurcating tree to the target 
organisms or viruses that will be incorporated into the 	 nucleic acid obtained from the test sample under condi- 
determination; 	 tions where a detectable signal will be produced by 
B. Obtaining or developing a bifurcating phylogenetic tree 	 signature probes that hybridize to the target nucleic acid 
having multiple nodes that establishes the genetic affin-  45 	 of the organism or virus and detecting such signals; 
ity between substantially all the organisms or viruses 	 G. Identifying the nodes in the bifurcating phylogenetic 
included in the nucleic acid sequence database; 	 tree of genetic relationship that are represented by the 
C. Computationally fragmenting each target nucleic acid 	 signature probes that produced detectable signal, in 
sequence such fragmentation being performed in a pro- 	 order to determine the genetic affinity of organisms or 
grammed computer so as to create a signature subse-  50 	 viruses in the test sample. 
quence database of all nucleic acid subsequences of 
	
2. A method of claim 1 wherein the signature probes com- 
length N where N is at least seven; 	 prise a moiety selected from the group consisting of: RNA, 
D. Tabulating in a programmed computer the extent to 	 DNA, an analog of RNA or DNA including peptide nucleic 
which the presence of each particular nucleic acid sub- 	 acids, 2-0-methyl DNA, branched DNA, and any other 
sequence of length N is characteristic of each node in the 55 nucleic acid molecule that can interact with the test sample 
bifurcating phylogenetic tree of genetic relationship by 	 nucleic acid by complementarity. 
examining the occurrence frequency of each subse- 	 3. A method of claim 1 wherein the hybridization step 
quence in the target nucleic acid of the organisms and 	 utilizes a feature selected from the group consisting of an 
viruses encompassed by or not encompassed by each 
	
immobilized array of signature probes, molecular beacons 
node in the tree to create a database of characteristic 6o and a hybridization step done in solution. 
signature sequences herein that extent is identified by: 	 4. A method of claim 1 wherein the detection step utilizes 
calculating the occurrence frequency and distribution of 	 radioactive labels, chemiluminescence and/or fluorescence. 
each subsequence of length N in the sequence database 	 5. A method of claim 1 wherein the bifurcating phyloge- 
and calculating a signature quality index which mea- 	 netic tree of genetic relationships is generated by parsimony 
sures the extent to which each subsequence of length N 65 method. 
is characteristic of each node in the bifurcating node 	 6. A method of claim 1 wherein the most narrowly defined 
phylogenetic tree of genetic relationships; 	 grouping on the tree of relationship comprises a moiety 
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selected from the group consisting of: specific genus, specific 
species, subgroups; strain, and serotype. 
7. A method of claim 1 in which the signature probes are of 
length 7 or larger and where the nucleic acid is selected from 
the group consisting of ribosomal RNA, genomic DNA, I OS 
RNA, RNAse, P RNA, guide RNA, telomerase RNA, snR-
NAs, scRNAs, and DNA isolated from the spacer region 
between ribosomal RNA genes and fragments of the forego-
ing. 
8. A method of claim 1 wherein the hybridization step 
comprises a feature selected from the group consisting of 
locked nucleic acids, polymerase chain reaction, RTI-PCR, 
peptide nucleic acids, array detection, and magnetic detec-
tion. 
9. A method of claim 1 in which the signature probes used 
have values of Qs averaging less than 0.95 when calculated by 
the equation: 
Q =(NcM/Ncr)X(1-(NM-NcM)/NM) 
_ (NcM) l (Ncr X NM ) 
in whichNM is the number of probe-matched organisms in the 
entire tree, NGM is the number of probe-matched organisms in 
the group of interest and NAT  is the number of organisms in 
the group under consideration. 
10. A method of claim 1 wherein the tree comprises 11 or 
more nodes. 
11. A method of claim 1 wherein the target nucleic acid 
comprises RNA or DNA. 
12. A method of claim 1 comprising selecting a target 
nucleic acid from the group consisting of: ribosomal RNAs, 
RNAse, P RNA, tmRNA and the DNA that encodes them, 
spacer region DNA from rRNA gene clusters, mitochondrial 
DNA, and viral genomic RNAs and DNAs. 
13. A method of claim 1 comprising computationally frag-
menting each target nucleic acid sequence such fragmenta-
tion being performed in a programmed computer so as to 
create a subsequence database of nucleic acid subsequences 
of length N that occur in at least two sequences in the nucleic 
acid database, where N is at least seven; and inspecting the 
location of positive nodes in the phylogenetic bifurcating tree 
to determine the genetic affinity of the organism or virus in the 
test sample. 
14. A method of claim 1 where the same target nucleic acid 
sequence is obtained from viruses. 
15. A method of claim 1 in which the nucleic acid database 
is comprised of at least 12 sequences of a target RNA or DNA, 
the sequences being derived from different organisms or 
viruses and being at least 30% identical over at least one 
subsequence of at least 50 nucleotides. 
16. A method of claim 1 wherein all subsequences of length 
7 or longer that occur in less than two sequences in the nucleic 
acid database are not considered when creating a database of 
characteristic signature sequences. 
17. A method for determining the genetic affinity of organ-
isms or viruses in a test sample containing a nucleic acid, 
comprising in combination the steps of: 
A. Obtaining or creating a nucleic acid sequence database 
of a plurality of sequences, each nucleic acid sequence 
46 
being from the same corresponding nucleic acid, from 
all organisms or viruses that will be incorporated into the 
determination; 
B. Obtaining or developing a bifurcating phylogenetic tree 
5 having multiple nodes that establishes the genetic affin-
ity between-the organisms or viruses included in the 
nucleic acid sequence database; 
C. Calculating the occurrence frequency and distribution 
of each subsequence of length N that occur in at least two 
10 sequences in the nucleic acid database, in the subse-
quence database; 
D. Tabulating in a programmed computer a signature qual-
ity index which measures the extent to which each sub-
sequence of length N is characteristic of each node in the 
15 bifurcating node phylogenetic tree of genetic relation-
ships by computationally fragmenting each target 
nucleic acid sequence such fragmentation being per-
formed in a programmed computer so as to create a 
subsequence database of nucleic acid subsequences of 
20 length N that occur in at least two sequences in the 
nucleic acid database, where N is at least seven; 
E. Deriving a plurality of signature probes from the signa-
ture database of characteristic signature sequences that 
will be complementary to a portion of the target nucleic 
25 acid sequence of the organism or virus if the signature 
sequence is present; 
F. Hybridizing the signature probes to the target nucleic 
acid obtained from the test sample under conditions 
where a detectable signal will be produced by signature 
30 probes that hybridize to the target nucleic acid of the 
organism or virus and detecting such signals; 
G. Identifying the nodes in the bifurcating phylogenetic 
tree of genetic relationship that are represented by the 
signature probes that produced detectable signal, in 
35 order to determine the genetic affinity of the organism or 
virus in the test sample. 
18. A method of claim 17 in which the signature quality 
index, Qs, is calculated by substantially the equation: 
40 
Q =(NGm/Ncr)X(1- (NM - NcM)/NM) 
_ (NcM) l (Ncr X NM ) 
45 inwhichNM is the number ofprobe-matched organisms inthe 
entire tree, N GM is the number of probe-matched organisms in 
the group of interest, and N AT  is the number of organisms in 
the group under consideration. 
19. A method of claim 1 in which the oligonucleotides or 
so sequences of length N comprise genes. 
20. A method of claim 17 in which a measure of signature 
quality is calculated by considering the frequency of occur-
rence of each subsequence of length N in a particular group of 
organisms or viruses as well as its presence in other organisms 
55 not belonging to that group of organisms or viruses. 
21. A method according to claim 17 wherein the tree com-
prises eleven or more nodes, N equals 7 or more and the 
nucleic acid database comprises 12 or more sequences and 
wherein the detection step comprises analysis by mass spec- 
60 trometer. 
